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7ABBREVIATIONS
AA arachidonic acid
BAPTA 1,2,-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
4-BPB 4-bromophenylacyl bromide
BCECF bis-(carboxyethyl)carboxyfluorescein
BSA bovine serum albumin
BzATP 2'&3'-O-(4-benzoylbenzoyl)adeosine 5'-triphosphate
[Ca2+]i intracellular concentration of free Ca2+
CaM calmodulin
cAMP cyclic AMP
cGMP cyclic GMP
CICR Ca2+induced Ca2+release
CIF Ca2+ influx factor
cPLA2 cytosolic phospholipase A2
CRE cAMP responsive element
DAG diacylglycerol
DPX 1,3-diethyl-8-phenylxanthine
ECL enhanced chemiluminescent
EET epoxyeicosatrienoic acid
EGF epidermal growth factor
ER endoplasmic reticulum
ERK extracellular signal regulated kinase
ETYA 5,8,11,14-eicosatetraynoic acid
FGF fibroblast growth factor
FRTL-5 Fisher rat thyroid cell line
G protein GTP-binding protein
GPCR G protein-coupled receptor
HBSS Hepes-buffered salt solution
HETE hydroxyeicosatetraenoic acid
HPETE hydroperoxyeicosatetraenoic acid
ICRAC Ca2+-release activated Ca2+current
IEG immediate early gene
IGF insulin-like growth factor
IP3 inositol-1,4,5-trisphosphate
LTB4 leukotriene B4
MAPK mitogen-activated protein kinase
MAPKKK mitogen-activated protein kinase kinase kinase
αβ−meATP αβ−methyleneATP
2-MeSATP 2-methylthioATP
MEK mitogen-activated protein kinase kinase
MEKK mitogen-activated protein kinase kinase kinase
NDGA nordihydroguaiaretic acid
OA oleic acid
PG prostaglandin
PIA (-)-N6-(2-phenylisopropyl)adenosine
8PIP2 phosphatidylinositol 4,5-bisphosphate
PKA protein kinase A
PKC protein kinase C
PLA phospholipase A
PLC phospholipase C
PLD phospholipase D
PMA phorbol 12-myristate 13-acetate
PS phosphatidylserine
PTX pertussis toxin
RTK receptor tyrosine kinase
RT-PCR reverse-transcriptase polymerase chain reaction
RyR ryanodine receptor
SH Src-homology
SOC store-operated Ca2+ channel
SRE serum-response element
TCA trichloroacetic acid
TM transmembrane
TRE TPA response element
TSH thyrotropin
9INTRODUCTION
ATP, a nucleotide consisting of an adenine base, a ribose sugar and a
triphosphate unit, is used as an energy source in muscles, in the movements of cells,
and in active transport. ATP also serves as a phosphate donor in biochemical
reactions and as a precursor for nucleic acid synthesis. Although first recognized as
intracellular molecules, the actions of extracellular adenine nucleotides on various
bodily functions have also been known for a long time. In 1929 Drury and Szent-
Györgyi published a study showing that adenosine and AMP had biological effects in
mammalian heart (Drury and Szent-Györgyi, 1929). In 1934 Gillespie demonstrated
that ATP and adenosine had separate effects on blood pressure, and that ATP was
more potent than AMP and adenosine in causing contraction of the guinea-pig ileum
and uterus (Gillespie, 1934). This was also the first hint of the existence of separate
receptors for ATP and adenosine. In 1972 Burnstock raised the possibility that ATP
acts as a neurotransmitter, and the term "purinergic" was introduced and purinergic
transmission proposed (Burnstock, 1972). In 1978 Burnstock proposed the existence of
specific extracellular receptors for adenosine and ATP (Burnstock, 1978). Since then,
along with the cloning of the first P2 receptors in the beginning of the 1990's,
knowledge of the actions and receptors of extracellular nucleotides has exponentially
expanded (Ralevic and Burnstock, 1998).
Today, receptors for ATP and other nucleotides have been found in
almost every cell type studied. Extracellular nucleotides have been shown to have a
wide physiological involvement both in normal cellular functions and in
pathological conditions. While the early investigations focused on ATP's effects on
the heart and the vasculature, the effects are now well known in the central nervous
system. There are also clear indications that ATP and other nucleotides have
regulatory actions in the cells of various endocrine tissues. Investigations in primary
thyroid cell cultures from different species and in thyroid cell lines have shown that
extracellular ATP is a true agonist in thyrocytes. These studies have focused mainly
on the mechanisms of regulation of Ca2+ fluxes evoked by ATP (Raspé et al., 1991;
Törnquist, 1992;  Törnquist, 1993), and some physiological responses such as
regulation of iodide fluxes and generation of H2O 2, events that are essential in
thyroid hormone synthesis (Nakamura and Ohtaki, 1990;  Raspé and Dumont, 1994).
In thyroid cells, ATP activates phospholipase C (PLC), which results in an increase in
free intracellular Ca2+ concentration, and phospholipase A2 (PLA2) and the
subsequent release of arachidonic acid (AA). Ca2+ is a central second messenger in
cells having effects on numerous cellular functions, such as secretion, gene
expression and cell proliferation (Carafoli and Klee, 1999). PLA2 activation with the
subsequent release of fatty acids from membranes have effects on e.g. iodide fluxes
and proliferation (Burch et al., 1986;  Di Girolamo et al., 1991). However, the
regulation of PLA2 activation in response to ATP, and the possible interaction of
these two pathways has not been thoroughly investigated in thyroid cells.
Furthermore, the mitogenic effect of ATP, which is recognized in many other cell
types, has not been investigated other than in thyrocytes of one animal species.
Finally, despite many studies showing the effect of ATP and other nucleotides on
thyroid cell functions, which may be indicative of the existence of several P2 receptor
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subtypes, no studies have been carried out to examine which receptor subtypes are
expressed in these cells.
In the present study, we have examined the effects of extracellular ATP in
a rat thyroid cell model, the FRTL-5 cell line. We have investigated the signal
transduction pathways evoked by ATP: the regulation of PLA2 activity in response to
ATP, and the effect of PLA2 activity on Ca2+ homeostasis. Furthermore, we have
examined which subtypes of P2 nucleotide receptors are expressed in these cells, and
investigated the effect of ATP and other nucleotides on DNA-synthesis and cell
proliferation.
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REVIEW OF THE LITERATURE
I EXTRACELLULAR ATP
1. Sources and degradation of extracellular ATP
 Cytosolic concentration of ATP in most cells is > 5 mM (Gordon, 1986).
ATP can thus be released from any cell into the extracellular space during tissue
injury and from dying cells. Cytosolic ATP can also be released by transmembrane
transport via specific transporter proteins in response to receptor activation in
vascular smooth muscle cells and endothelial cells (Sedaa et al., 1990). ATP may be
stored in granules or vesicles from which it is released by exocytosis. Exocytotic release
may occur from nerve terminals, where ATP is co-released with classical transmitters
and neuropeptides in most major nerve types (Burnstock, 1972), and from platelets.
ATP and UTP may also be released from cells by different environmental stressors
such as mechanical stress, and recent studies have demonstrated a basal release of
nucleotides from resting cells in vitro (Lazarowski et al., 2000). The mechanism of the
release is however unresolved (Lazarowski et al., 1995;  Pedersen et al., 1999). In the
thyroid gland, sympathetic and parasympathetic nerve terminals reach the thyroid
follicles and thus could theoretically be the source of ATP (Van Sande et al., 1980). Rat
thyroid FRTL-5 cells have also been shown to release adenosine (Vainio et al., 2000).
Once released, extracellular ATP can locally reach biologically active levels
from nanomolar to micromolar concentrations (Gordon, 1986;  Lazarowski et al.,
1995). The half-life of extracellular ATP is short, and ATP is rapidly broken down by
ectoenzymes to  ADP, AMP and adenosine. Adenosine is further degraded by
adenosine deaminase to form inosine. Presently, there is no evidence of carrier-
mediated cellular uptake of nucleotides, whereas nucleosides and nucleobases are
taken up by several transport systems (Griffith and Jarvis, 1996).
2. Physiological actions of extracellular ATP
Receptors for ATP and other nucleotides have been identified in a
remarkable variety of cell types, and extracellular nucleotides have been shown to
affect diverse cellular and tissue functions. In the central and peripheral nervous
system, ATP acts as a co-transmitter with other classical neurotransmitters in many
different nerve types (Burnstock, 1972). It mediates fast synaptic transmission between
neurones in autonomic ganglia and the medial habenula (Edwards and Gibb, 1993). A
role for P2 receptors in memory and learning (Inoue et al., 1996;  Wieraszko et al.,
1989;  Wieraszko and Seyfried, 1989), as well as in nociception (Burnstock, 1996) has
been demonstrated. At neuroeffector junctions ATP regulates the contraction of
visceral smooth muscle cells. ATP and adenosine regulate also vascular tone by acting
through receptors on endothelial and vascular smooth muscle cells (Ralevic and
Burnstock, 1998). ATP has a role also in exo- and endocrine secretion (Abbracchio and
Burnstock, 1998). In the testis, extracellular nucleotides have been shown to induce
testosterone secretion from Leydig cells, and in pancreas activation of P2Y receptors
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results in insulin secretion (Foresta et al., 1996;  Petit et al., 1998). In the immune
system, ATP has an anti-inflammatory effect (Abbracchio and Burnstock, 1998).
ATP has also long term actions in cells by affecting cell growth and
differentiation in both embryonic development and adulthood (Abbracchio and
Burnstock, 1998). ATP induces DNA-synthesis and proliferation in several different
cell types either on its own, or synergistically with other mitogens (Erlinge et al., 1993;
Huang et al., 1989;  Huwiler and Pfeilschifter, 1994;  Neary et al., 1994;  Van Daele et
al., 1992;  Wang et al., 1992). However, in cells where ATP has been reported to act as
an independent mitogen, synergism with other growth factors produced in an
autocrine fashion cannot be excluded (Erlinge, 1998). In vascular smooth muscle cells
extracellular ATP is probably involved in the development of atherosclerosis and
possibly hypertension through induction of cell proliferation (Erlinge et al., 1998). In
the kidney, ATP induces cell proliferation and enhances recovery from renal
ischemia (Paller et al., 1998). Extracellular nucleotides may contribute to the
regulation of chondrocyte function in both bone growth and during trauma and
inflammation (Kaplan et al., 1996). Extracellular ATP may also cause cell death in a
variety of cells, or it may have protective roles in pathological conditions such as
cancer, stress, bone resorption and traumatic tissue damage (Abbracchio and
Burnstock, 1998).
ATP stimulates the production of H2O2 in porcine and dog thyrocytes in
primary culture, and in rat thyroid FRTL-5 cells (Björkman and Ekholm, 1992;
Nakamura and Ohtaki, 1990;  Raspé et al., 1991). It also regulates iodide efflux in dog
thyrocytes and in FRTL-5 cells (Okajima et al., 1988;  Raspé and Dumont, 1994;
Smallridge and Gist, 1994). ATP evokes Ca2+ fluxes in thyroid cells of different species,
including human, dog and FRTL-5 cells (Rani et al., 1989;  Raspé et al., 1989;  Raspé et
al., 1991;  Schöfl et al., 1995;  Törnquist, 1992), and activates phospholipase D (PLD) in
dog thyrocytes (Lejeune et al., 1996). In dog thyrocytes, ATP is not a mitogen (Dumont
et al., 1992). However, its effect on proliferation has not been tested in the thyrocytes
of other species.
3. Receptors for extracellular nucleotides and nucleosides
Extracellular nucleotides interact with receptors located on the plasma
membrane. The receptors are divided into P1 and P2 receptor classes, which mediate
distinct responses evoked by adenosine and ATP, respectively (Burnstock, 1978;
Alexander and Peters, 2000).  Within both receptor classes there are several receptor
subtypes.
3.1 P2 receptors
The P2 receptors were originally classified into P2X and P2Y receptors based
on pharmacological studies on the activity of ATP analogues and antagonists
(Burnstock and Kennedy, 1985). New subtypes were then proposed: a platelet P2T
receptor selective for ADP, a P2Z receptor, which represented an ATP-activated
conductance pore in mast cells, a P2 D  receptor selective for diadenosine
polyphosphates, and a P2U receptor for both ATP and UTP (O'Connor et al., 1991).
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Later, it was realized that ATP was acting through two different transduction
mechanisms in cells, and along with the cloning of the first receptors, a new
classification was proposed: P2X or transmitter-gated ion channel receptors, and P2Y
or G protein-coupled receptors (Abbracchio and Burnstock, 1994). Due to the lack of
specific agonists and antagonists for P2 receptors, pharmacological knowledge still lag
behind the cloning studies, thus making firm conclusions difficult to draw in systems
where there are several different P2 subtypes expressed. Also, along with the
discovery of more P2 subtypes expressed than expected on the basis of
pharmacological studies, some previously published results have to be reevaluated.
3.1.1 P2Y subtypes
The G protein-coupled P2Y receptors typically have seven transmembrane
domains (7TM) with an extracellular N-terminus and an intracellular C-terminus
(Figure 1). Binding sites for the nucleotides have been localized to the 6th and 7th TM
domains (Burnstock, 1997).
Figure 1. Structure of a P2Y receptor. S-S indicates a predicted disulfide bridge.
To date, eight G protein-coupled P2 receptors have been cloned, five from
mammalian (human, rodent) sources (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11), two avian
receptors (P2Y1 and P2Y3) and one from Xenopus laevis  (p2y8) (North and Barnard,
1997). The cloned mammalian receptors can be divided into three groups: 1) the
purine receptors P2Y1 and P2Y11, 2) the pyrimidine receptors P2Y4 (human) and P2Y6,
and 3) purine/pyrimidine receptors P2Y2 and P2Y4 (rat). The P2Y11 subtype is so far
the only ATP-selective P2Y receptor. The distribution and agonist selectivities of the
mammalian receptors are summarized in Table 1.
All of the cloned mammalian P2Y receptors are coupled to Gq/G11 proteins and
activate phospholipase C (PLC) (Ralevic and Burnstock, 1998). However, the P2Y1
receptor may in some native cells couple to the Gi/Go pathway, and instead of
generating IP3, increases intracellular Ca2+ by inhibiting adenylate cyclase (Webb et al.,
1996). The P2Y2, P2Y4 and P2Y6 receptors are also coupled to Gi/Go proteins (Filippov
et al., 1999;  Ralevic and Burnstock, 1998). The P2Y11 receptor apparently activates both
PLC and adenylate cyclase, and is thus unique among P2Y receptors (Communi et al.,
1999). The P2Y type receptors in some rat neurones have been shown to be linked to
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the activation of a K+- and Ca2+-channels, and this coupling is G protein-mediated
(North and Barnard, 1997).
TABLE 1. Cloned mammalian P2Y receptors.
Subtype                      Distribution                    Agonists*              References
P2Y1 Wide distribution; brain, spinal
cord, pancreas, vascular endothelial
cells, platelets
2MeSADP>ADP≥ATPγS>
αβmeATP**
Schachter et al., 1996
Ayyanathan et al., 1996
Henderson et al., 1995
Tokuyama et al., 1995
Léon et al., 1997
P2Y2 Wide distribution; epithelial cells,
vascular smooth muscle cells, bone
UTP≥ATP>Ap4A=ATPγS>>
UDP=2MeSATP=αβmeATP
Lustig et al., 1993
Parr et al., 1994
Bowler et al., 1995
P2Y4 Placenta, brain, several peripheral
organs
UTP, UTPγS>>ATP  (human)
UTP =ATP (rat)
Communi et al., 1996
Nguyen et al., 1995
Webb et al., 1998
Bogdanov et al., 1998
P2Y6 Spleen, vascular smooth muscle,
wide distribution in brain
UDP>>UTP>2MeSATP, ADP Communi et al., 1996
Chang et al., 1995
P2Y11 Placenta, spleen, granulocytes ATP>2MeSATP>>ADP Communi et al., 1997
van den Weyden et al.,
2000
* Studies have shown that absolute nucleotide selectivity is likely to vary to a certain degree across
species.
** Currently it is uncertain whether or not ATP is an agonist at the P2Y1 receptor (Fagura et al., 1998;
Léon et al., 1997).
3.1.2 P2X subtypes
The P2X receptors are transmitter-gated ion channels (Barnard, 1996).
They do not exhibit sequence similarity with the other ligand-gated ion channel
families and are therefore considered to represent a third major class of these
receptors (North, 1996). P2X receptors consist of at least three receptor subunits (Nicke
et al., 1998), each of which has two hydrophobic TM segments M1 and M2, short
intracellular N- and C-termini, and a large cysteine-rich extracellular loop (Figure 2).
Although it is not certain, the conserved cysteines in the extracellular loop could
form a binding site for ATP through the formation of a network of disulfide bonds
(Barnard et al., 1997). The M2 domain have been demonstrated to be involved, at least
in part, in pore formation (Nicke et al., 1998;  Rassendren et al., 1997). The channels
open within milliseconds, and are permeant to K+, Na+ and Ca2+ (Humphrey et al.,
1995)
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Figure 2. Structure of a P2X receptor subunit. S-S indicates a predicted disulfide bridge.
M1 and M2, membrane-spanning segments; H5, a hydrophopic segment.
To date, seven P2X receptor subunits designated P2X1-7 have been cloned from
mammalian cells. Receptor distribution and agonist selectivities are summarized in
Table 2. All P2X receptor subunits can form homomeric channels, but it is likely that
in native cells they exist as heteromeric assemblies (Nicke et al., 1998). At least the
recombinant P2X2/3, P2X1/5 and P2X4/6 subunits form heteromeric channels when
coexpressed in cultured cells (Lé et al., 1998;  Lewis et al., 1995;  Torres et al., 1998),
however not all subunit combinations may be possible (Surprenant, 1996).
TABLE 2. Cloned mammalian P2X receptors.
Subtype                     Distribution                     Agonists             References
P2X1 Visceral and vascular smooth
 muscle, sensory ganglia
ATP=2MeSATP≥αβmeATP≥
ATPγS>ADP
Valera et al., 1994
Bo and Burnstock, 1993
Longhurst et al., 1996
P2X2 Autonomic and sensory ganglia,
various brain nuclei , retina
ATP≥ATPγS≥2MeSATP>
ADP>>αβmeATP
Brake et al., 1994
Lewis et al., 1995
Kidd et al., 1995
Greenwood et al., 1997
P2X3 Nociceptive sensory neurones 2MeSATP≥ATP≥αβmeATP Chen et al., 1995
Lewis et al., 1995
P2X4 Brain, pancreas, glands, central
nervous system
ATP≥ATPγS≥2MeSATP>>
ADP≥αβmeATP
Bo et al., 1995
Soto et al., 1996
P2X5 Mesencephalic trigeminal
nucleus neurones, sensory nerves
ATPγS≥ATP≥2MeSATP>
ADP>>αβmeATP
Collo et al., 1996
Khakh et al., 1997
P2X6 Brain, autonomic ganglia,
epithelial cells
2MeSATP≥ATP≥ATPγS>
ADP>>αβmeATP
Collo et al., 1996
Soto et al., 1996
P2X7 Macrophages, lymphocytes,
mast cells, microglia
BzATP>ATP>2MeSATP>
ATPγS>>αβmeATP
Rassendren et al., 1997
*The predominant subunit considered to be involved.
The P2X receptors are principally activated by ATP, with the other nucleotides having
very low potency (McLaren et al., 1998;  North and Barnard, 1997). The receptors can
broadly be divided into three groups. The first group, which is comprised of receptors
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consisting of P2X1 and P2X3 subunits, is almost equally activated by ATP and the
stable analogue αβ-meATP. The P2X3 is also activated by 2-MeSATP. The second
group of P2X2, P2X4, P2X5 and P2X6 receptors is not activated by αβ-meATP, but the
P2X4 and P2X5 receptors are activated by ATPγS and 2-MeSATP. The third group is
formed by the P2X7 receptor (former P2Z), which is relatively insensitive to ATP, and
sensitive to BzATP (MacKenzie et al., 1999).
 3.2 P1 receptors
There are four cloned and pharmacologically characterized adenosine P1
receptors: A1, A2A, A2B and A3 (Ralevic and Burnstock, 1998). They all belong to the G
protein-coupled receptor family. The A1 receptor subtype couples to Gi/Go proteins
(Freissmuth et al., 1991;  Munshi et al., 1991). The most widely recognized signaling
pathway for the A1 receptor is inhibition of adenylate cyclase which results in a
decrease in the intracellular cAMP level (Van Calker et al., 1978). The receptor also
affects other effector systems, i.e. activation of PLC leading to Ca2+ mobilization,
inhibition of N-, P- and Q-type Ca2+ channels, and opening of K+ channels (Ralevic
and Burnstock, 1998). Both A2A and A2B receptors are positively coupled to adenylate
cyclase via Gs proteins and thus increase intracellular cAMP levels (Ralevic and
Burnstock, 1998). The A2B receptors may also activate PLC (Yakel et al., 1993), possibly
via Gq/G11 proteins (Feokistov and Biaggioni, 1997). The A3 receptor couples to Gi
and to a lesser extent to Gq/11 proteins (Palmer et al., 1995). The receptor stimulates
PLC and inhibits adenylate cyclase (Ralevic and Burnstock, 1998).
3.3   P1 and P2 receptors in thyroid cells
In thyroid cells, no molecular characterization of the different P1/P2
receptor subtypes present has been made. There are, however, functional studies
suggesting the presence of several P1 and P2 receptor subtypes in thyroid cells. In
human thyroid cells in primary culture, on the basis of intracellular Ca2 +
experiments, the P2U receptor is suggested to be the predominant P2 receptor type
(Schöfl et al., 1995). A UTP-preferring P2 receptor mediating inhibition of Na+
transport has been proposed in porcine thyroid cells (Bourke et al., 1999). In FRTL-5
cells, one or more receptor types for ATP have been suggested. They are thought to be
coupled to distinct signal transduction pathways, that are the activation and
inhibition of adenylate cyclase, and the activation of PLC (Okajima et al., 1989;  Sato et
al., 1992). In FRT thyroid cells, a cell line derived from FRTL-5 cells, the presence of a
P2 receptor-operated Ca2+ channel has been suggested (Aloj et al., 1993). Of the P1
receptors, the A1 and A2B subtypes may function in FRTL-5 cells (Vainio et al., 2000;
Nazarea et al., 1991). The A2B subtype may be expressed at a lower level than A1
(Vainio, 2000).
In thyroid as well as in other cell types, P1 receptors may interact with
other G protein-coupled receptors, and this may result in potentiation or inhibition of
their responses (Okajima et al., 1989;  Ralevic and Burnstock, 1998;  Tomura et al.,
1997). In FRTL-5 cells it has been shown that (-)-N6-(2-phenylisopropyl)adenosine
(PIA), an adenosine derivative, which binds to the A1 subtype, may potentiate e.g. the
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effects of thyrotropin (TSH) and noradrenaline, both of which activate the PLC-
pathway (Sho et al., 1991). Also, potentiation of the P2 receptor-evoked Ca2+-responses
by adenosine or a derivative has been observed (Nazarea et al., 1991;  Vainio and
Törnquist, 2000). On the other hand, stimulation of the A1 subtype inhibits the TSH-
mediated increase in cAMP levels, which may indicate a physiological feedback
mechanism (Vainio et al., 2000).
II THE THYROID GLAND
1. The thyroid gland and thyroid FRTL-5 cells
The thyroid gland is an endocrine organ located just below the larynx. It
produces and secretes two hormones, thyroxine (T4) and triiodotyronine (T3). The
thyroid gland, through the action of thyroid hormones, increases the overall
metabolic rate of the body, has both general and specific effects on e.g. growth,
carbohydrate and fat metabolism, the cardiovascular system, respiration, and on the
central nervous system.
The thyroid gland consists mainly of thyrocytes (70%), which are arranged
in follicles. Other cell types in the thyroid tissue are fibroblasts (10%) and endothelial
cells of the capillaries (20%). The follicles are filled with a secretory substance called
colloid. The major constituent of colloid is thyroglobulin, a glycoprotein synthetized
by the thyroid cells. The follicles are encapsulated by small ramifications of a capillary
network. Each of the capillary endothelial cells has hundreds of endothelial
fenestrations which may allow the passage of nutrients, signaling factors, and
products between the capillaries and the interstitial and cellular compartments
(Köhrle, 1990). There are also scarce calcitonin-secreting parafollicular cells located in
the periphery of the follicles (Dumont et al., 1992).
Thyroid cells concentrate iodide by actively pumping it from the
extracellular fluid at the basal membrane. Iodide ions are oxidized to iodine by
thyroid peroxidase and H2O2 at the apical membrane. Thyroglobulin, which contains
tyrosine residues, is then iodinated by the thyroid peroxidase enzyme. Tyrosine is first
iodinated to monoiodotyrosine and then to diiodotyrosine. Two diiodotyrosine
residues become coupled to form T4, and a mono- and a diiodotyrosine couple to
form T3. The thyroid hormones remain as part of the thyroglobulin molecule until
secreted. Upon secretion, colloid is ingested in small portions by thyroid cells by
endocytosis, and lysosomes immediately fuse with these vesicles. Lysosomal
proteases cleave the peptide bonds between the iodinated residues and thyroglobulin,
and T4 and T3 are released into the cytoplasm, from which they diffuse into the blood
(Guyton and Hall, 1996).
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Figure 3. Thyroid cellular mechanism for synthesis of thyroid hormones. 1. Iodide is
transported from the blood to the cell by an active pump. 2. Thyroid peroxidase
enzyme (TPO) oxidizes iodide  (I-) to iodine (I2), which then 3. binds to thyroglobulin
(TGB). 4. Droplets of colloid enter the cell by endocytosis, and merge with lysosomes,
thus releasing free T4 and T3. 5. The lipid soluble T4 and T3 diffuse through the
plasma membrane to enter the blood.
The FRTL-5 cell line, derived from Fischer rat thyroid follicular cells
(Ambesi-Impiombato et al., 1980), is a model for thyroid cells. The cells maintain
many of the thyroidal functions, such as sensitivity to TSH, iodide concentration
(Ambesi-Impiombato et al., 1980;  Weiss et al., 1984), thyroglobulin synthesis and
secretion (Avvedimento et al., 1984;  Di Jeso et al., 1993). FRTL-5 cells grow as
monolayers and do not form follicles. In addition, they do not synthetize or secrete
thyroid hormones. However, when stimulated, they release iodide into the
extracellular medium, and iodinate thyroglobulin (Corda et al., 1985;  Marcocci et al.,
1987).
2. Intracellular signal transduction systems
2.1 G proteins
Guanine nucleotide binding proteins (G proteins) comprise a superfamily
of GTPases that couple plasma membrane receptors to their effector molecules. The
heterotrimeric G proteins consist of α, β and  γ subunits, and are attached to the
cytoplasmic surface of the plasma membrane. The activated receptors promote G
protein activation by stimulating the release of GDP from an α subunit, which then
binds a GTP molecule causing dissociation of the α subunit from the βγ subunit. The
dissociated subunits, α-GTP and free βγ, can then both bind to effector molecules and
regulate their activity. The α  subunit possesses intrinsic GTPase activity, and
hydrolysis of GTP to GDP inactivates the G protein, and allows the subunits to
reassociate (Wess, 1997).
Generally, the G proteins are named after their α subunits. The Gs
proteins stimulate adenylate cyclase, whereas the Gi proteins mediate inhibition of
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adenylate cyclase. The Gq/11 proteins regulate the activity of phospholipase C. The
Gi/o proteins are sensitive to inhibition by pertussis toxin (PTX), whereas Gs proteins
are sensitive to cholera toxin. The Gα subunits Gs (Berg et al., 1994;  Laugwitz et al.,
1996), Gi-2 (Laugwitz et al., 1996), Gi1-3 (Berg et al., 1994), Go, Gq (Laugwitz et al., 1996;
Nikmo et al., 1999), G12 and G13 (Nikmo et al., 1999) have been identified in FRTL-5
cells.
2.2 Receptor tyrosine kinases
The receptor tyrosine kinases (RTKs) are a family of transmembrane
polypeptides with a protein tyrosine kinase domain in their intracellular portion.
RTKs are involved in the control of cell growth, differentiation and cell survival.
Upon binding their corresponding agonist, of which many are dimeric molecules, the
receptors undergo dimerization. This promotes transphosphorylation of the receptor
subunits on tyrosine residues, and activation of the catalytic domains. The
autophosphorylated dimers recruit cytoplasmic substrates that have an increased
affinity for the phosphorylated tyrosine residues. A common feature of many
substrate molecules is that they contain Src-homology (SH) domains, e.g. PLCγ, the
phosphoinositide 3-kinase and small adaptor proteins such as Shc and Grb2. A
number of intracellular signaling pathways have been shown to be activated by RTKs.
These include the phosphoinositide 3-kinase, 70 kDa S6 kinase, mitogen-activated
protein kinase, phospholipase Cγ, and the Jak/STAT pathways. A single type of RTK
can elicit very different biological responses in different cell types (Fantl et al., 1993).
Among the RTK subfamilies there are insulin-like growth factor-I (IGF-I)
and II (IGF-II) receptors and insulin receptors, of which the receptors for insulin and
IGF-I are closely related (Fantl et al., 1993). Both insulin and IGF-I receptors have been
found in thyroid cells, and there is much evidence that insulin and IGF-I may bind to
each other's receptors (Eggo and Sheppard, 1994). Other RTKs in thyroid cells are the
receptors for fibroblast growth factor (FGF) and epidermal growth factor (EGF) (Eggo
and Sheppard, 1994).
2.3 Phospholipase C
 Phospholipase C (PI-PLC) specifically hydrolyzes a plasma membrane
phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), resulting in formation of
two second messengers, inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3
is released into the cytosol where it binds to specific receptors located in the
endoplasmic reticulum (ER) and mediates the release of sequestered Ca2+ (Berridge,
1995). DAG remains in the plasma membrane where it binds to protein kinase C
(PKC) and promotes its activation (Nishizuka, 1992).
In mammalian cells there are at least ten isoforms of PI-PLC which are
divided into β, γ and δ subfamilies. The PLC β isoforms (β1, β2, β3, β4) have been
shown to be activated by G protein-coupled receptors, whereas PLC γ is activated by
binding to receptor-tyrosine kinases (Rhee and Bae, 1997). In FRTL-5 cells, the PLC β3
have been shown to be the dominant subtype (Laglia et al., 1996).
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The α  subunits of the Gq subfamily of G proteins have been shown to
specifically activate the four PLC β isoforms (Morris and Scarlata, 1997;  Singer et al.,
1997). All of the PLC β isoforms may also be activated by the βγ subunits, but β2 and
β3 are more sensitive than β1 and β4 (Clapham and Neer, 1993;  Neer, 1995;  Singer et
al., 1997). The βγ subunits activate PLC with lower potency than the α subunits
(Singer et al., 1997). The activation by βγ subunits suggests that any G protein may
stimulate PLC activity. This is thought to be the mechanism by which the Gi proteins
mediate PTX-sensitive stimulation of PLC activity (Singer et al., 1997).
2.4 Calcium signaling
Ionized free Ca2+ is the most widely used second messenger in organisms
(Clapham, 1995). Ca2+ signaling involves a rise in the cytosolic Ca2+ concentration,
which  may vary in the magnitude, location and duration (Barritt, 1999). Prolonged
elevated Ca2+ levels are harmful to cells and therefore cells tightly regulate [Ca2+ ]i.
Resting free cytosolic [Ca2+ ]i in cells is maintained at low concentrations (10-200 nM)
by the action of intracellular and plasma membrane Ca2+ pumps, and by diverse
intracellular Ca2+-binding proteins, such as calreticulin and calsequestrin (Clapham,
1995). Cells store Ca2+ in the ER and in mitochondria (Hofer et al., 1998, Babcock et al.,
1997). A large electrochemical gradient between the cell interior and exterior is the
driving force for rapid increases in [Ca2+ ]i in response to various signals. The gradient
between the cytosol and ER ([Ca2+] in ER is 0.4 mM) is also large, thus enabling rapid
Ca2+ fluxes also inside the cells.
2.4.1 Ca2+ release
Intracellular Ca2+ concentrations can be increased by two mechanisms: by
release from internal Ca2+ stores, and by movement of Ca2+ into the cells from the
extracellular space. Release from the internal stores in the ER is mediated by IP3 acting
on its receptors (IP3R). The tetrameric IP3R functions as a ligand-gated channel and
activation by IP3 leads to the rapid release of Ca2+ to the cytoplasm. The IP3-mediated
signal can increase [Ca2+]i from ~100 nM to ~1 µM (Clapham, 1995). The N-terminal
region of the receptor extends to the cytoplasm containing binding sites for e.g. IP3,
Ca2+ and ATP (Berridge, 1995). It is thought that during very strong receptor-mediated
stimulation, the generated IP3 may act directly to release Ca2+. However, at normal
physiological stimulation levels IP3 may increase the sensitivity of the IP3R to Ca2+,
resulting in a process called Ca2+ induced Ca2+ release (CICR). This enables Ca2 +
released from one IP3R to excite its neighbors, which causes spontaneous calcium
spikes and waves. The Ca2+ release is usually transient and fully deactivates within
tens of seconds (Parekh and Penner, 1997).
2.4.2 Ca2+ influx
Ca2+ influx from the extracellular space occurs through channels in the
plasma membrane. The Ca2+ influx pathways may broadly be divided into voltage-
dependent and voltage-independent ones. Voltage-dependent Ca2+ channels are
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expressed in exitable cells, and are affected by the membrane potential. The voltage-
independent influx pathways may consist of numerous channel subtypes, which are
activated by different mechanisms. These influx pathways include 1) ligand-gated
non-specific cation channels, 2) second messenger-operated channels which are
activated by mobile intracellular messengers such as cyclic GMP (cGMP), cyclic AMP
(cAMP), IP3, IP4, and arachidonic acid or its metabolites, 3) a cytoplasmic Ca2 +
increase, 4) channels activated by a trimeric G protein, and 5) store-operated Ca2+
channels (SOCs; formely called the capacitative Ca2+ entry) (Putney and Bird, 1993).
The store-operated Ca2+ influx pathway is coupled to the Ca2+ content of
the store such that the empty store transmits a signal to the plasma membrane to
open Ca2+ channels (Putney, 1999). The best characterized store-operated Ca2+ current
is the Ca2+-release-activated Ca2+ current (ICRAC) (Hoth and Penner, 1992). The current
is activated equally by dialysis with IP3 via a patch pipette, receptor stimulation or by
using thapsigargin, a sesquiterpene lactone which inhibits the ER Ca2+ATPase pump
irreversibly (Parekh et al., 1997). It seems likely that refilling of the stores turns off the
Ca2+ influx, although this has been shown only in a few investigations. However, the
mechanism of the inactivation of influx has not been revealed (Parekh and Penner,
1997).
There are two models to explain how the depleted store provokes entry of
extracellular Ca2+. In the first model, the empty store releases a diffusible factor which
then serves as a messenger to activate the entry pathway. Proposed messengers
include Ca2+ influx factor (CIF), cGMP, small G proteins, tyrosine kinase, arachidonic
acid or its metabolites (Barritt, 1999). In the second model, the emptying of the store
induces a reversible coupling of ER with the plasma membrane to activate SOCs. The
channel is activated and maintained by contact with the IP3R, which are moved to the
vicinity of SOCs (Berridge, 1995;  Ma et al., 2000). In most cells, Ca2+ entry after
stimulation with agonists can be explained by activation of SOCs, but neither the
mechanism nor the molecular nature of the plasma membrane channels mediating
Ca2+ entry has been definitively established. The possibility that combinations of
some or all of these elements regulating the Ca2+ entry cannot be excluded. Also, cell
type specific mechanisms may also exist.
In many cell types agonists may open more than one type of voltage-
independent Ca2+ entry pathways (Barritt, 1999). In FRTL-5 cells there are no voltage-
operated Ca2+ channels (Törnquist, unpublished observation). However, a second-
messenger-operated (Törnquist and Ekokoski, 1995), as well as store-operated
(Törnquist, 1992) Ca2+ entry pathways have been shown to be activated in response to
ATP in these cells.
2.4.3  Ca2+ as a regulator of cellular  functions
Ca2+ can alter a tremendous number of cellular processes, e.g. contraction,
secretion, metabolism, cell survival, and proliferation (Parekh and Penner, 1997). In
thyroid cells, Ca2+ signaling has roles in various functions, such as thyroid hormone
synthesis through generation of H2O2 and iodide efflux (Raspé and Dumont, 1994),
gene expression (Saji et al., 1991), and cell proliferation (Burch et al., 1986;  Takada et
al., 1990).
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Ca2+ acts by affecting the activity of many intracellular targets, such as
protein kinases, phospholipases, phosphatases and ion channels (Clapham, 1995).
Ca2+ may modify protein function by directly binding to a specific region or domain.
For example, enzymes such as protein kinase C, PLC and PLA2 all contain a Ca2+-
binding C2-domain, which target them to substrate membranes (Nalefski et al., 1994;
Ron and Kazanietz, 1999). Ca2+ ions may also act through the Ca2+-receptor proteins,
e.g. calmodulin. The Ca2+-calmodulin complex can modulate functions of different
target proteins, including the Ca2+/calmodulin-dependent (CaM) protein kinases
(Schulman and Braun, 1999).
In proliferating cells, Ca2+ and calmodulin have a regulatory role at the
G1/S boundary of the cell cycle, and it is thought that calmodulin is also required for
re-entry of G0 cells into the cycle, in transition from G2 to mitosis and in the
anaphase-metaphase transition (Santella, 1998). Very likely, many of the actions of
calmodulin are mediated by CaM kinase II. Although not much is known about the
substrates of CaM kinase II in the cell cycle, one possible target could be the tyrosine
phosphatase cdc25 (Means et al., 1999). Ca2+  and calmodulin may also regulate gene
expression. Both immediate early and late genes have been shown to be Ca2+-
inducible (Carafoli and Klee 1999). Ca2+ may also affect transcription elongation, the
stability of mRNA and its translation (Santella and Bolsover, 1999).
2.5 Protein kinase C
Protein kinase C is a family of serine/threonine kinases which takes part
in many cellular functions including receptor functions, ion transport, metabolism
and cell proliferation (Toker, 1998). There are several PKC isoforms, which are
divided into three subgroups: conventional PKCs (cPKCs: α, β1, β2, γ), which are
regulated by DAG, phosphatidylserine (PS) and Ca2+; novel PKCs (nPKCs: δ, ε, η, θ)
which are regulated by  DAG and PS but are not dependent on Ca2+; and atypical PKCs
(aPKCs: ζ, λ) whose  regulation has not been clearly established, but are phorbol ester
and Ca2+-insensitive (Newton, 1997). In FRTL-5 cells, the PKC isoforms α, βΙ, βΙΙ, γ, δ,
ε, ζ and η have been identified (Wang et al., 1996;  Wang et al., 1995).
The activation of PKC includes association of the enzyme with PS, which
is controlled by Ca2+ in the case of the cPKCs. The membrane-associated enzyme can
then bind DAG, which leads to conformational change and activation of PKC. The
DAG analogues, phorbol esters, such as 12-myristate 13-acetate (PMA), can bind to and
activate cPKCs and most nPKC isoforms but not aPKCs (Ron and Kazanietz, 1999).
Free fatty acids have been shown to enhance the DAG induced activation of some
PKC isoforms (Khan et al., 1993;  Shinomura et al., 1991). Recent studies indicate that
PKCs may also become phosphorylated by upstream kinases on residues which are
usually required for protein kinase activity (Toker, 1998). Phosphoinositide-
dependent protein kinase-1 may be the universal PKC upstream kinase (Toker, 1998).
PKC phosphorylates a number of substrates, which are both membrane-
associated and soluble targets, indicating that the substrates may diffuse to PKC,
and/or PKC may itself relocate. The substrates include receptors, other kinases, ion
channels and cytoskeletal proteins (Toker, 1998). A well known target is the Raf-1
kinase of the MAP kinase cascade (Widmann et al., 1999). PKC may also modulate
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agonist-evoked Ca2+ signals, probably by affecting receptor-G protein coupling or by
activating receptor kinases, or by affecting ICRAC (Oppermann et al., 1996;  Parekh and
Penner, 1995;  Pronin and Benovic, 1997).
2.6 Phospholipase A2
The A2 phospholipases (PLA2s) are a family of enzymes that catalyze the
hydrolysis of membrane phospholipids at the sn-2-position, resulting in liberation of
free fatty acids and lysophospholipids (Leslie, 1997). The most common fatty acid
present in mammalian phospholipids is the 20-carbon unsaturated arachidonic acid
(AA) (Moncada and Higgs, 1988). The major sources of AA are phosphatidylcholine,
phosphatidylethanolamine and phosphatidylinositol (Exton, 1994). PLA2 activation
has been implicated in diverse cellular responses, such as signal transduction, host
defense, proliferation, blood coagulation and membrane remodeling (Murakami et
al., 1997). In human thyroid cells and in FRTL-5 cells, the activation of PLA2 and the
concomitant release of AA are involved in different cellular functions, such as
regulation of iodide efflux and proliferation (Burch et al., 1986;  Di Paola et al., 1997;
Marcocci et al., 1987;  Smallridge and Gist, 1994).
PLA2 enzymes are divided into several groups based on their structure
and enzymatic characteristics (Dennis, 1997). Among these are the small (13-15 kDa)
secreted forms of PLA2 (sPLA2s), and high molecular mass (80-85 kDa) PLA2s, which
are cytosolic enzymes and lack sequence homology with the secreted forms of PLA2
(Clark et al., 1991). Although the sPLA2s and cPLA2 catalyze the same reaction, their
catalytic mechanisms are different: millimolar Ca2+ is necessary for sPLA2 catalytic
activity, whereas submicromolar Ca2+ is essential for cPLA2 translocation to
membranes, rather than for catalytic activity (Leslie, 1997). Furthermore, cPLA2 can
selectively liberate AA from membrane phospholipids (Murakami et al., 1997),
whereas sPLA2s does not show any preference for fatty acid at the sn-2 position
(Mayer and Marshall, 1993). Recent investigations have revealed a coordinated role
for some of the sPLA2 and cPLA2 in the release of AA, at least in hematopoietic cells
(Balsinde and Dennis, 1996). In this system, cPLA2 activation precedes the subsequent
activation of sPLA2, which is responsible for the bulk release of AA. However, also in
this system, the cPLA2  has a key regulatory role.
A novel group of PLA2s are the Ca2+-independent forms of the enzyme
(iPLA2s), with molecular masses ranging from 29 to 85 kDa. The iPLA2s are also
capable of releasing AA at least in aortic smooth muscle cells (Murakami et al., 1997).
There are conflicting reports of the role of iPLA2 in the cells, some describing a role in
signal transduction, others suggesting an involvement in membrane phospholipid
remodeling (Murakami et al., 1997).
2.6.1 Activation of cPLA2
 The cPLA2 may be activated by many growth factors, cytokines,
neurotransmitters, hormones and other extracellular signals acting through G
protein-coupled receptors, and through receptor tyrosine kinases (Murakami et al.,
1997). The activation process of PLA2 is complex and not completely understood.
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Many G protein-coupled receptors activate both PLC and PLA2 (Cockroft and
Stutchfield, 1989), and studies have suggested that the activation of PLA2 is a
consequence of PLC activation. PLA2 can also be activated independently of PLC
through separate G proteins (Burch et al., 1986;  Smallridge and Gist, 1994).  In some
studies a direct activation of PLA2 by a GTP-binding protein has been suggested (Ando
et al., 1992;  Xing and Mattera, 1992). However, this type of activation has not finally
been established, and some studies suggest an effector between a G protein and the
PLA2 enzyme (Burch et al., 1986;  Winitz et al., 1994). Recent studies suggest a role for
a Gαi-type protein in the regulation of PLA2 independently of phosphorylation and
Ca2+ levels (Burke et al., 1997;  Murray-Whelan et al., 1995).
Agents that increase intracellular Ca2+ concentration have been shown to
cause AA release, suggesting that an increase in [Ca2+]i is essential for the activation of
c P L A 2 (Kramer and Sharp, 1997). In vitro, purified cPLA2 is active at Ca2 +
concentrations of 0.1 - 1 µM (Piomelli, 1993). The cPLA2 enzyme contains a Ca2+-
dependent phospholipid binding domain in the N-terminal portion (Nalefski et al.,
1994). This kind of domain is also found in PKC and PLC, which have been
demonstrated to translocate to phospholipid membranes in a Ca2+-dependent
manner (Murakami et al., 1997). The cPLA2 translocates to membranes in the
presence of submicromolar concentrations of Ca2+, the nuclear envelope and
endoplasmic reticulum being the primary target membranes (Clark et al., 1991;
Schievella et al., 1995;  Yoshihara and Watanabe, 1990). The Ca2+- i n d u c e d
translocation may take place over a small distance not even visible at the
ultrastructural level. It has been suggested that the translocation should be considered
as a tighter interaction of the enzyme with the membranes in stimulated cells (Bunt
et al., 1997).
cPLA2 has been shown to have multiple phosphorylation sites, including
Ser-437, Ser-454, Ser-505, Ser-727 (de Carvalho et al., 1996), of these the Ser-505 is
thought to be crucial for activation (Qiu et al., 1993;  Rao et al., 1994). cPLA2 have been
demonstrated to be a substrate for several kinases, e.g. mitogen-activated protein
kinase (MAPK), p38 kinase, PKC, CaM kinase II and PKA (Leslie, 1997). The
phosphorylation is an independent phenomenon of the Ca2+ induced translocation
from cytosol to membranes. Furthermore, phosphorylation per se is not sufficient for
cPLA2 activation in intact cells (Murakami et al., 1997), but phosphorylation,
nevertheless, regulates cPLA2 activity. A scheme for PLA2 activation is presented in
Figure 4.
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Figure 4. The mechanisms of activation of cPLA2. Stimulation of a G protein-coupled
receptor may activate both Gq and Gi proteins. Both of these may activate PLC, which
then leads to activation of PLA2 through formation of IP3 and DAG. IP3  releases Ca2 +
from intracellular stores and the influx of extracellular Ca2+  is also activated. The rise
in cytosolic Ca2+  induces translocation of PLA2 to the substrate membranes. DAG
activates PKC, which either directly, or indirectly through the MAP kinase cascade,
phosphorylates PLA2. PLA2 may also be activated independently of PLC, probably
through a Gi protein.
2.6.2 Arachidonic acid metabolism
In addition to PLA2, AA may also be released by the sequential action of
PLC and diacylglyserol lipase. After release, free AA may diffuse out of the cell, it may
be reincorporated into phospholipids, or it can be converted to potent lipid mediators,
eicosanoids. The eicosanoids are formed by cyclooxygenase, lipoxygenase and
cytochrome P-450 enzymes (Fitzpatrick and Murphy, 1989;  Moncada and Higgs, 1988).
The cyclooxygenase pathway gives rise to stable prostaglandins e.g. PGE2, PGD2, PGI2,
PGF2, prostacyclins and thromboxanes. Leukotrienes A4, B4, C4, D4, E4 and 5-, 12- and
15-hydroxyeicosatetraenoic acids are produced by the lipoxygenase pathway. Cis-
epoxyeicosatrienoic acids 5,6-EET, 8,9-EET, 11,12-EET and 14,15-EET are formed via the
epoxygenase pathway, where the cytochrome P-450 monooxygenase enzyme catalyzes
the oxidation of AA and conversion into epoxyeicosatrienoic acids, which are then
hydrolyzed to corresponding diols by epoxide hydrolase (Fitzpatrick and Murphy,
1989;  Piomelli, 1993). Other P450 metabolites are hydroxyeicosatetraenoic acids such
as 12-HETE and 15-HETE (Fitzpatrick and Murphy, 1989).
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Figure 5. Overview of AA metabolism. The enzymes are given in italics.
The eicosanoids may act both as intracellular second messengers and as
local mediators, and have a variety of effects both on normal and pathophysiological
processes. Besides their action in inflammation, some prostaglandins may increase
cell proliferation in a variety of cells, including FRTL-5 cells (Burch et al., 1986).
Leukotrienes and cytochrome P-450-derived metabolites may take part in the
regulation of cell proliferation (Chen et al., 1998;  Harris et al., 1990), but they may also
activate and inhibit different ion channels. For example, EETs are considered
important regulators of vascular tone (Imig et al., 2000), by activating Ca2+-dependent
K +-channels (Baron et al., 1997) or by enhancing Ca2+ influx through voltage-
dependent Ca2+-channels (Fang et al., 1999). In cardiac L-type Ca2+ channels, EETs act
as inhibitors (Chen et al., 1999). Leukotrienes and EETs may also mobilize Ca2+ on
their own (Luscinskas et al., 1990;  Snyder et al., 1986), or enhance the agonist-evoked
Ca2+ release (Force et al., 1991). They have also been reported to regulate the store-
operated Ca2+ influx (Hoebel et al., 1997;  Mombouli et al., 1999;  Rzigalinski et al.,
1999).
2.6.3 Free fatty acids
PLA2 also cleaves other polyunsaturated fatty acids, especially those with
three cis double bonds between carbons 5 and 6, 8 and 9, and 11 and 12 (Murakami et
al., 1997). It has been reported that the order of preference of sn-2 fatty acids for PLA2 is
arachinoyl > linolenoyl > linoleoyl > oleoyl > palmitoleyl (Murakami et al., 1997).
Free fatty acid concentration may thus locally increase after agonist stimulation.
A variety of fatty acids regulate the activity of specific ion channels. In
exitable cells they may activate or inhibit voltage-operated Ca2+ channels (Huang et
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al., 1992;  Shimada and Somlyo, 1992). AA has been shown to activate different types
of K+ channels in cardiac cells and in smooth muscle cells (Kim and Clapham, 1989;
Ordway et al., 1989). Polyunsaturated fatty acids block Na+ channels in neonatal rat
cardiac myocytes (Kang and Leaf, 1996). A recent report has shown that
polyunsaturated fatty acids activate the Drosophila light-sensitive Ca2+ channels TRP
and TRPL (Chyb et al., 1999). AA and other unsaturated fatty acids have been reported
to promote Ca2+  entry  (Alonso et al., 1990), or inhibit store-operated calcium influx
(Gamberucci et al., 1997). They are also reported to enhance Ca2+ extrusion after
agonist stimulation, possibly by activating Ca2+ATPase (Randriamampita and
Trautmann, 1990). They may affect different cellular functions such as adenylate and
guanylate cyclase activation, Na+/K+-ATPase activity, and activation of PKC (Piomelli,
1993;  Shirai et al., 1998).
2.7 The cAMP-dependent pathway
 In thyroid cells the cyclic AMP-protein kinase A pathway is one of the
main signaling systems. cAMP is formed from ATP by a membrane-bound enzyme,
adenylate cyclase. cAMP activates protein kinase A (PKA), a serine/threonine kinase,
which phosphorylates other enzymes and proteins. Depending on the cell type,
activation of the cAMP-pathway may result in cell proliferation, differentiation or
growth arrest (McKenzie and Pouysségur, 1996).
2.7.1 Adenylate cyclases
Through its interaction with receptors and G proteins, adenylate cyclase
activity is regulated by hormones, neurotransmitters and other regulatory molecules
(Hanoune et al., 1997). Today nine isoforms of adenylate cyclases have been cloned
and characterized from mammalian cells (Ishikawa and Homcy, 1997). All of the
isoforms are activated by Gsα protein, although probably not equally effectively.
Likewise, inhibition by the inhibitory G protein, Giα, may not be equal for all the
isoforms and may depend on the type of the isoform and the activator of the enzyme
(Hanoune et al., 1997). Other potential regulators are Gβγ subunits, Ca2+/calmodulin,
divalent metal cations and other kinases. Forskolin is a natural diterpene that is able
to activate all isoforms (Hanoune et al., 1997).
2.7.2 Protein kinase A
cAMP activates PKA by binding to the regulatory subunits of the
tetrameric enzyme, and facilitates the dissociation of the dimeric catalytic subunit
from the regulatory one.  The activated free catalytic subunit not only phosphorylates
cytoplasmic substrates, but can also migrate into the nucleus, where it can
phosphorylate proteins important for the regulation of gene transcription, such as the
cAMP response element binding protein (CREB). Free cAMP, but not cAMP bound to
the regulatory unit, is rapidly inactivated by cyclic nucleotide phosphodiesterases
(PDEs). The catalytic subunits are inactivated by reassociation with regulatory dimers
(Hanoune et al., 1997).
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2.8 The MAP kinase  pathway
The mitogen-activated protein kinases (MAP kinase) comprise several
parallel kinase cascades, which are activated by various extracellular stimuli and
mediate diverse cellular responses depending on the cell context. There are at least
three subgroups of MAP kinases in mammalian cells, differing in substrate specificity
and regulation.  The core unit of a MAP kinase pathway is a three-member protein
kinase cascade. The MAP kinase is the terminal serine/threonine kinase, which is
phosphorylated and activated by MAP kinase kinase (MEK) on tyrosine and
threonine residues. MEK is in turn phosphorylated by MAP kinase kinase kinases,
such as Raf or MEKK, on serine/threonine residues (Widmann et al., 1999).
The first MAP kinase cascade to be characterized in detail was the
extracellular signal regulated kinase (ERK) pathway (Cobb et al., 1991). In the
literature, the names MAP kinase and ERK are used interchangeably. In the
following, this ERK pathway will be referred to as MAP kinase pathway.  This
pathway regulates different cellular functions such as growth, proliferation and
differentiation. MAP kinase occur as two different isoforms p42 and p44 kDa. MAP
kinase has been established as an especially important regulator of transcription
factors, such as Elk-1, Ets-1 and c-Myc (Widmann et al., 1999). Several cytoplasmic
targets have also been implicated, including cytoskeletal proteins (e.g. tau) and
microtubule-associated proteins, membrane proteins such as EGF and NGF receptors,
cPLA2, and protein tyrosine phosphatase 2C (Widmann et al., 1999).
2.8.1 Coupling of cell surface receptors to the MAP (ERK) kinase cascade
Signaling from the receptor tyrosine kinases (RTKs) to MAP kinase is well
established (Fig. 6). A general activation scheme involves the activation of a RTK,
which serves as a docking site to recruit SH2 domain containing adaptor proteins,
such as Shc and growth factor receptor-bound protein 2 (Grb2). This promotes binding
of the guanine nucleotide exchange protein Sos to the SH3 domain of Grb2, leading to
recruitment of the GTP binding protein Ras to the signaling complex (Widmann et
al., 1999). Ras then binds Raf, a MAPKKK, targeting it to the plasma membrane where
Raf activity is increased by a yet unclear, and apparently complex multistep
mechanism (Morrison and Cutler, 1997). Raf then phosphorylates MEK 1 and 2
(MAPKKs), thereby activating them. The activated MEK 1,2 then phosphorylate
ERK1/ERK2 on threonine and tyrosine residues (Anderson et al., 1990).
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Figure 6. Receptor tyrosine kinase-mediated activation of the MAP kinase cascade.
Binding of the ligand to a receptor tyrosine kinase (RTK) leads to receptor
dimerization and autophosphorylation. The receptor then serves as a docking site for
adaptor molecules such as Grb2 or Shc. These molecules, either singly or in
combinations, link the receptor to the guanine nucleotide exchange protein Sos,
which catalyzes GDP release and GTP binding to Ras. Ras then binds Raf and recruits
it to the plasma membrane, where the activity of Raf is increased. Raf then
phosphorylates Mek1,2 , which in turn phosphorylates the MAP kinases.
The activation of the MAP kinase cascade by the GPCRs is less clear, and
apparently more complex than the RTK signaling system (Figure 7). The cascade
becomes activated through Gi/o and Gq/11 proteins (Hawes et al., 1995), and
depending on the G protein and also cell type, the signal transduction pathways
leading to the MAP kinase cascade may vary (Della Rocca et al., 1997). The α subunit
of the Gq/11 proteins may mediate activation of MAP kinase (Della Rocca et al., 1997),
whereas the βγ subunit may mediate the Gi protein induced activation of MAP
kinase (Crespo et al., 1995). Downstream mediators of βγ might be the tyrosine
kinases of the Src-family and the adaptor protein Shc. In contrast, the Gq/11 coupled
receptor activates MAP kinase via a PKC-dependent pathway, which does not involve
βγ and Ras (Hawes et al., 1995). Activation of MAP kinase by PKC activators, such as
phorbol esters, have been reported, and this may occur through both Ras-dependent
and Ras-independent pathways (Gutkind, 1998). Recent studies have shown that the
GPCR-induced activation of MAP kinase requires RTK transactivation. However the
mechanism is poorly understood, although a regulatory role for Gβγ subunits, Src
kinases, Ca2+ and PKC have been suggested (Luttrell et al., 1999;  Widmann et al.,
1999).
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Figure 7. Gq and Gi protein-mediated activation of the MAP kinase cascade. A) Gq
protein activates PLCβ , which hydrolyzes plasma membrane phosphatidylinositol
PIP2, leading to formation of IP3 and DAG. IP3 releases Ca2+ from intracellular stores,
which together with DAG promotes the activation of PKC. PKC then phosphorylates
Raf and activates the concomitant MAP kinase cascade. B) Activation of the MAP
kinase cascade by a Gi protein most likely occurs through the βγ  subunits. A ligand-
independent transactivation of a RTK may follow, and the activated RTK then serves
as a structural scaffold for assembly of the signaling molecule complex which
resembles that formed when the RTK is activated by its own ligand. The mechanism
of transactivation is presently not known, although it may involve a Src-family
tyrosine kinase or a nonreceptor tyrosine kinase PYK2.
There have been a number of reports that increasing intracellular cAMP
inhibits MAPK activity, via phosphorylation of Raf-1 by protein kinase A. This
apparently leads to reduction in the affinity of Raf for Ras (Häfner et al., 1994), and
decreases the activity of Raf.
2.9 Immediate early genes c-fos and c-jun
The primary genomic response to a variety of external stimuli is the rapid
induction of a set of genes, named immediate-early response genes (IEGs) or primary
response genes (Herschmann, 1991). IEGs are functionally defined by their rapid and
transient induction in response to a variety of treatments, including growth factor
stimulation. IEGs encode transcription factors, which bind to specific target DNA
sequences and affect downstream gene expression. Their activation has strongly been
related to mitogenesis, but they are also induced in postmitotic cells by various
signals.
There are several transcription factor families of which the transcription
factor AP-1 is a collection of dimers composed of the Jun (c-Jun, JunB, JunD), Fos (c-
Fos, Fra-1, Fra-2, FosB) and ATF families of basic region-leucine zipper DNA binding
proteins (Ransone and Verma, 1990). These dimers bind to a common cis acting
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element known as the TRE (TPA response element) or the AP-1 site (Angel and
Karin, 1991). Jun proteins can form homodimers, and any of the Jun proteins can
form heterodimers with c-Fos and Fra-1 proteins (Karin, 1995), whereas Fos proteins
can not form homodimers. In many cells stimulation of proliferation is accompanied
by an increased expression of c-fos and c-jun. The participation of c-Fos and c-Jun in
proliferation has been intensively investigated. However, no unified roles for
different mitogens has been found, since some mitogens induce proliferation without
inducing AP-1 activity (Columbano et al., 1997;  Menegazzi et al., 1997). Also their
target genes are largely unknown, although some have been recently identified, such
as cyclin A and D (Brown et al., 1998;  Sylvester et al., 1998).
In quiescent cells the expression level of c-Fos and c-Jun is low or
nondetectable. Enhanced expression of c-fos can be mediated by multiple signal
transduction pathways involving cAMP, Ca2+, and PKC, and MAPK (Herschmann,
1991;  Karin, 1995). A serum response element (SRE) in the c-fos gene promoter
mediates c-fos induction by growth factors and cytokines. CRE or cAMP responding
element mediates the effects of Ca2+ and cAMP on c-fos. The c-jun promoter is
simpler and most of its inducers operate through one major cis element, TRE (Karin,
1995). An increase in [Ca2+]i has been considered important for IEG expression in
several cell types (Cesnjaj et al., 1994;  Negulescu et al., 1994;  Roche and Prentki, 1994;
Werlen et al., 1993). Also, phosphorylation at specific sites enhances the activity of c-
Fos and c-Jun (Karin, 1995).
3. Regulation of thyroid cells
The thyroid functions include events that are involved in the synthesis of
thyroid hormones and their secretion. The hormone synthesis requires uptake and
concentration of iodide, synthesis of thyroglobulin, and an oxidation system to
iodinate tyrosyl groups in thyroglobulin and couple them into iodothyronines
(Vassart and Dumont, 1992). Thyrotropin (TSH), secreted from the anterior pituitary,
is the main regulator of thyroid functions (Dumont et al., 1992). Together with
thyroid hormones it forms a negative feedback mechanism: the thyroid cells secrete
thyroid hormones that inhibit the secretion of TSH from the pituitary. Whenever the
secretion of thyroid hormones decreases, TSH secretion increases, which causes an
activation of thyroid functions and growth (Vassart and Dumont, 1992). Various
hormones, growth factors and cytokines also regulate the thyroid functions. The
thyroid gland is under regulation of sympathetic and parasympathetic nerves, and the
nerve terminals also reach the thyroid follicles (Amenta et al., 1978;  Melander et al.,
1975;  Van Sande et al., 1980).
3.1 Regulation of function
TSH regulates the sodium-dependent influx of iodide into thyrocytes in
the basal membrane by a cAMP-dependent pathway (Weiss et al., 1984). The
production of H2O2, an essential oxidant in the peroxidase reactions catalyzed by
thyroid peroxidase (Kimura et al., 1995;  Nakamura and Ohtaki, 1990), is stimulated in
response to activation of the PLC/Ca2+-pathway in all species studied (Björkman and
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Ekholm, 1992;  Raspé et al., 1991; Raspé and Dumont, 1994). It is activated by the cAMP
pathway in only a few species, including rat FRTL-5 cells (Björkman and Ekholm,
1992;  Roger et al., 1997). No evidence has been found for acute second messenger
regulation of the thyroid peroxidase; the activity depends only on its expression level
and the availability of substrates (Vassart and Dumont, 1992). Iodide efflux, which in
FRTL-5 cells is proposed to be related to the in vivo process by which iodide is
transported to the lumen and coupled to thyroglobulin, is stimulated by the PLC-
pathway, but not by the cAMP-pathway (Weiss et al., 1984). Studies have shown that
in addition to PLC, activation of the PLA2 pathway is essential in the activation of
iodide efflux in FRTL-5 cells (Marcocci et al., 1987;  Smallridge and Gist, 1994).
3.2 Regulation of growth
In a developing thyroid, the proliferation of thyrocytes is fast, and
dependent on TSH (Dumont et al., 1992). In an adult organism, the thyroid gland cells
have a slow constant turnover. However, the cells do retain the capability to grow by
hypertrophy and proliferation in response to a stimulus (Dumont et al., 1992). In
general, the growth of thyroid cells, including FRTL-5 cells, is regulated by TSH
(Dumont et al., 1992). This effect has mainly been attributed to the TSH-evoked
elevation of cAMP and the activation of PKA. However, in WRT cells, another rat
thyroid cell line, TSH is mitogenic also through a cAMP-independent pathway, which
is dependent on Ras, but not on Raf-1 or MEK (al-Alawi et al., 1995;  Kupperman et
al., 1993).
The thyroid produces autocrine growth factors, e.g. IGF-I, IGF-II, EGF and
FGF (Eggo and Sheppard, 1994). Depending on the species, these growth factors have
been shown to be mitogenic or comitogenic (Deleu et al., 1999;  Dumont et al., 1992).
The effect of insulin mainly involves the IGF-I receptor in dog thyrocytes, however at
high (5 µg/ml) concentrations it activates both its own receptor and the IGF-I receptor
(Deleu et al., 1999). It has been shown in vitro and in vivo that the action of TSH is in
part dependent on other hormones, e.g. insulin and IGF-I and II (Cheung et al., 1996;
Deleu et al., 1999;  Taton and Dumont, 1995). The synergistic effect of TSH and
insulin/IGF-I has been suggested to involve elevation of 1,2-diacylglycerol, and thus
activation of PKC in FRTL-5 cells (Brenner-Gati et al., 1988). It has recently been
shown that TSH and IGF-I or insulin, separately control DNA-synthesis and cell
growth, and complement each other in mitogenesis (Deleu et al., 1999). At least in dog
thyrocytes, HGF is the only growth factor which elicits all the events required for cell
proliferation, i.e. protein accumulation and DNA-synthesis (Deleu et al., 1999).
The activators of the PLC pathway in dog thyroid cells have been shown
to have no or only marginal mitogenic activity (Roger et al., 1997). However, a role
for Ca2+ in FRTL-5 cell proliferation has been shown (Brenner-Gati et al., 1988). Also,
activation of PKC by phorbol esters stimulates thyroid cell proliferation (Lombardi et
al., 1988;  Roger et al., 1997).
Iodide exerts an endogenous negative feedback control on thyrocyte
growth (Dumont et al., 1992). Iodide deficiency increases the sensitivity of the thyroid
to the goitrogenic effects of TSH. Iodide has been shown in several thyroid culture
systems to regulate transforming growth factor β mRNA levels, with induction at
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iodide concentrations inhibitory to thyroid growth and function (Eggo and Sheppard,
1994). Another growth regulating factor in the thyrocytes is adenosine, the effect of
which is dependent on other growth factors such as insulin and TSH (Moses et al.,
1989;  Vainio et al., 1997).
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AIMS OF THE STUDY
The aims of the study were to investigate the actions of extracellular ATP
in FRTL-5 thyroid cells by examining the ATP-activated signal transduction pathways.
Specifically, the following themes were examined:
• The regulation of PLA2 activity in response to ATP  (I)
•The regulation of ATP-evoked Ca2+-fluxes by arachidonic acid metabolites (II)
• The effects of fatty acids on ATP-induced Ca2+ signals (III)
• Determination of P2 receptors in FRTL- 5 cells (V)
• The effect of ATP and other nucleotides on FRTL-5 cell DNA-synthesis and 
immediate early gene expression (IV, V)
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METHODS
1. Cell culture
Several batches of the rat thyroid FRTL-5 cells were used in this study.
The cells, originally obtained from the Interthyr Foundation, were kindly donated by
Dr. Egil Haug (Aakers Hospital, Oslo, Norway) and by Dr. Leonard Kohn (NIH, MD,
USA). The cells were cultured in Coon's modified Ham's F 12 medium
supplemented with 5% new born calf serum and six hormones (6H medium,
Ambesi-Impiombato et al., 1980): insulin, 1 µg/ml; transferrin, 5 µg/ml;
hydrocortisone, 10 nM; the tripeptide gly-L-his-L- lys, 10 ng/ml; TSH, 0.3 mU/ml;
somatostatin, 10 ng/ml. The cells were grown in a humidified atmosphere of 5% CO2
and 95% air at 37°C. The medium was changed every 2-3 days.
2. Measurement of intracellular Ca2+ concentrations
Cells grown in 6H medium were harvested and loaded with 1 µM Fura
2/AM or with 2 µM Fluo-3 in Hepes buffered saline solution (HBSS: NaCl, 118 mM;
KCl, 4.6 mM; CaCl2, 0.4 mM; glucose, 5 mM; Hepes, 20 mM; pH 7.2) for 30 min at 37°C.
Fluorescence was monitored with a Hitachi F2000 fluorimeter. The excitation
wavelengths were 340 nm and 380 nm and the emission wavelength was 510 nm for
Fura 2. When using Fluo-3, the exitation wavelength was 506 nm and the emission
wavelength 526 nm. [Ca2+]i was calculated as described (Grynkiewicz et al., 1985) with
a computer program using the Kd-value of 224 nM for Fura 2. For Fluo-3 the [Ca2+]i
values were calculated using the formula: (F-Fmin/Fmax-F)Kd. The Kd-value for Fluo-3
was 390 nM.
3. Measurement of intracellular Ca2+ concentrations in permeabilized cells
 The cells were harvested and permeabilized by first washing the cells
twice in buffer A (KCl, 125 mM; Hepes, 25 mM; KH2PO4, 2 mM; EGTA, 0.25 mM; pH
7.0 and BSA, 1 mg/ml) by centrifugation (80 g, 5 min). The cells were then allowed to
equilibrate in buffer A for 5 min at 37 °C, whereafter they were permeabilized with 5
µM digitonin. The efficiency of permeabilization was continuously monitored by
trypan blue uptake. After 2-4 min incubation with digitonin, ice-cold buffer B (buffer
A without EGTA) was added and the cells were washed twice by centrifugation (80 g, 5
min). The cells were then loaded with 2 µM Fura 2/AM for 20 min at 37 °C. The cells
were then washed with buffer B and kept on ice until use. [Ca2+]i measurements were
then carried out as described above.
4. Measurement of intracellular  pH
The cells were harvested and loaded with 5 µM BCECF/AM for 35 min at
37 °C. pHi was determined using excitation wavelengths 440 and 500 nm and
emission wavelength 530 nm. The calibration method was as described (Törnquist
and Alinen, 1992). Briefly, the cells were lysed with Triton-X 100 to obtain pHmax, and
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the actual pH was measured with a pH meter. Then HCl was added to obtain pHmin,
and again actual pH was measured. The actual pH values from the experiments were
then calculated using the two known pH values and fluorescence values from the
calibration.
5. Measurement of membrane potential
The cells were harvested, and bisoxonol (final concentration 100 nM) was
added to the cells and they were allowed to stabilize for 10 min at 37 °C. Membrane
potential was assessed using an exitation wavelength of 540 nm and an emission
wavelength of 580 nm (Rink et al., 1980). After each experiment, 50 mM KCl was
added to enable comparisons between separate experiments.
6. Measurement of 45Ca2+ fluxes
Calcium fluxes were measured as described by Tan and Tashjian (1981).
The cells were grown on 35 mm dishes until confluent. In influx experiments the
cells were preincubated in BSS-buffer (Hepes, 18 mM; NaCl, 130.6 mM; KCl, 5.9 mM;
CaCl2, 0.4 mM; MgCl2, 1.2 mM; glucose, 11.8 mM; pH 7.2), for 10 minutes at 37 °C. The
buffer was replaced with 1 ml of fresh BSS containing the test substances and 1 µCi
45Ca2+. In efflux experiments the cells were incubated with BSS containing 1 µCi
45Ca2+  and 5 mM NaHCO3 for 3 h at 37 °C. The cells were then washed twice with
warm BSS and the test substances were added in 1 ml of BSS. In both methods, after
an appropriate incubation time, the solution was aspirated and the cells were washed
rapidly three times with ice-cold BSS. Then 750 µl of 0.1 N NaOH was added and
solubilized, and 600 µl was removed and counted for radioactivity in a Rackbeta
liquid scintillation counter.
7. 3H-Arachidonic acid release
The cells were incubated with 3H-AA (0.1 µCi/ml) for 24 h in 35 mm
dishes. After the incubation, the cells were washed three times (5-min intervals) with
release buffer (Hepes, 10 mM; NaCl, 134 mM; KCl, 4.7 mM; KH2PO4, 1.2 mM; MgSO4,
1.2 mM; CaCl2, 2 mM; NaHCO3, 2.5 mM; glucose, 5 mM; pH 7.4 and 0.1 % BSA). The
cells were then incubated with the appropriate agents in 750 µl of the release buffer at
37 °C. After the appropriate incubation times, 600 µl was removed and counted for
radioactivity in a Rackbeta liquid scintillation counter.
8. Measurement of 3H-thymidine incorporation
The cells were plated onto 35 mm-dishes and grown in 6H-medium for 3-
4 days. Where indicated, the medium was changed to 5H-medium lacking TSH and
allowed to grow for an additional 2 days. The cells were then stimulated in medium
containing tritiated thymidine (0.4 µCi/ml) and incubated for 24 h. They were then
washed 2 times with ice-cold PBS (in mM: NaCl, 137; KCl, 2.7; Na2HPO4, 8; KH2PO4,
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1.5; pH 7.4) and then with cold 5 % trichloroacetic acid (TCA). The TCA-insoluble
precipitate was dissolved in 0.1 N NaOH and the radioactivity was measured.
9. Phorbol ester binding assay
For the phorbol ester binding assay, the cells were plated on microtitration
plates and cultured until confluent. After three washes with AA buffer, 3H-phorbol-
12,13-dibutyrate (final conc. 10 nM) was added to the cells, and the cells were then
stimulated. Non-specific binding was assessed by using PMA (1 µM). The incubations
were stopped by washing the cells with ice-cold HEPES-buffered saline. The wells
were counted for their radioactivity in a Wallac Microbeta counter.
10. SDS-PAGE and Western blotting
In protooncogene experiments, cells grown in 5H medium or 0H (without
hormones or serum) in 35 mm-dishes were stimulated with appropriate agents and
incubated for the times indicated at 37 °C. The cells were then washed with ice-cold
PBS, scraped from the dishes and lysed in ice-cold lysis buffer (in mM: Tris Base, 20;
NaCl, 420; EDTA, 2; Na3VO4, 2; pH 8 and NP-40, 3%). In MAP kinase studies the cells
were detached and the experiments were carried out in cell suspension in HBSS, and
the cells were then lysed in the lysis buffer mentioned above, containing 100 mM of
NaCl. The supernatant was mixed with an equal volume of Laemmli sample buffer
x2 (Tris, 125 mM, SDS, 4%, glycerol, 20%, 2-mercaptoethanol, 10%, bromophenol blue,
0.02%) and boiled for 2 min. The protein contents of the samples were determined by
the Lowry method (Lowry et al., 1951) or using a BCA kit (Rockford, IL, USA). Equal
amounts of protein were analyzed on a 10% SDS-polyacrylamide gel, transferred to a
nitrocellulose membrane (Bio-Rad, Hercules, CA) and probed with a 1:1000 (c-Raf-1,
MAP kinase), 1:20 000 (phospho MAPK), 1:500 (c-Fos, c-Myc) or 1:250 (c-Jun) dilution
of the antibodies. The proteins were detected using the Enhanced
Chemiluminescence (ECL) kit from Amersham.
11. RT-PCR
Total RNA from FRTL-5 cells was prepared using Tryzol (Gibco BRL,
Paisley, UK) according to the manufacturer's instructions. First strand cDNA was
prepared from 5 µg of total RNA using an oligo(dT) 18 primer and Moloney-murine
leukemia virus Reverse Transcriptase (Gibco BRL) according to the manufacturer's
instructions. PCR reactions were carried out with the four rat P2Y (P2Y1, P2Y2, P2Y4,
P2Y6) and all seven P2X subtype specific primer pairs designed to amplify partial
cDNAs for each receptor subtype as described previously (Michel et al., 1998;  Webb et
al., 1998). Briefly, the PCR reactions were performed using 7.5% (v/v) of each first
strand cDNA reaction and 400 ng of each  primer using 2.5 units of either Biotaq
(Bioline, London, UK) or Dynazyme DNA polymerase (Flowgen, Sittingbourne, UK)
with the appropriate buffer, 200 µM of each deoxy-nucleotide triphosphate and 1.5
mM MgCl2. Amplification conditions for the P2Y receptors were 1 min at 94 °C, 30 sec
at 60 °C, 1 min at 72 °C for 30 cycles and, finally 10 min at 72 °C. Amplification
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conditions for the P2X receptors were 1 min at 94 °C, 30 sec at 58 °C for all subtypes
other than P2X3 which was annealed at 60 °C, 1 min at 72 °C for 35 cycles and, finally,
10 min at 72 °C. The amplification products were separated electrophoretically and
visualised with ethidium bromide fluorescence.
12. Cloning and sequencing
FRTL-5 PCR products were cloned into the pCR 2.1 vector (TA cloning kit;
Invitrogen, Leek, The Netherlands) according to the manufacturer's instructions and
sequenced completely using an automated DNA sequencer.
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RESULTS AND DISCUSSION
1. Regulation of PLA2 activity and arachidonic acid release by ATP (I)
The activation of PLA2 and the concomitant release of AA are involved
in different cellular functions in FRTL-5 cells, such as regulation of iodide efflux,
proliferation and Ca2+ fluxes (Burch et al., 1986;  Smallridge and Gist, 1994). In general,
studies have suggested that two events are essential for the activation process of
c P L A 2, i.e. the Ca2 +-dependent translocation to the membranes, and the
phosphorylation of the enzyme (Murakami et al., 1997), although even these together
may not be sufficient (Balboa et al., 2000). Another important question has been to
what extent do G proteins play a role in the activation process (Burke et al., 1997).
1.1 Roles of G proteins and Ca2+
ATP evoked a concentration- and time-dependent 3H-AA release from
prelabelled FRTL-5 cells (I, Fig. 1A, B). Typically, the release was 1-2% of the total
incorporated 3H-AA (data not shown). Treating the cells with a Gi/Go protein
inhibitor PTX (100 ng/ml for 24 h) completely inhibited the AA release stimulated by
100 µM ATP (I, Fig. 1C), a result which is consistent with an earlier study by Okajima
et al. (Okajima et al., 1989). The ATP-evoked Ca2+-signal was also sensitive to PTX-
treatment, but it is decreased only by 29% (V, Table 2). Furthermore, preventing the
influx of extracellular Ca2+ significantly decreased, but did not abolish, the ATP-
evoked AA release. (I, Fig. 2A) Thus, the influx of Ca2+ does play an important role in
the ATP-evoked PLA2 activation. In an earlier study Smallridge and Gist (Smallridge
and Gist, 1994) stated that the ATP-evoked AA release is Ca2+-independent. However,
although ATP evoked a significant release of AA in EGTA-treated cells, it was still
significantly smaller than in control cells, and thus the conclusion of these authors
seems to be incorrect.
There are numerous examples where Ca2+ ionophores evoke AA release,
suggesting that an increase in [Ca2+]i alone is sufficient for PLA2 activation
(Murakami et al., 1997). Also we have shown that the ER Ca2+-ATPase inhibitor
thapsigargin evokes release of AA, which is totally blocked in the presence of EGTA
(Törnquist et al., 1994), but which is PTX-insensitive (Ekokoski and Törnquist,
unpublished observation). Thus, depending on the stimulating agent, there seems to
be a different demand for elevated [Ca2+]i and for involvement of a G protein. A
minimum length of stimulation (2-5 min, depending on the cell type) of elevated
[Ca2+]i has been shown to be essential for continuous translocation, and complete
activation, of cPLA2 (Hirabayashi et al., 1999). A brief increase in [Ca2+]i induces the
translocation of PLA2 and a weak binding to the membranes, but the still inactive
PLA2 may readily translocate back. Only a continuous [Ca2+]i increase evokes stronger
binding to membranes and AA release. It is thus possible that the [Ca2+]i increase
evoked by ATP is not sustained enough in FRTL-5 cells and, thus, coupling to a G
protein could promote the activation of PLA2. In embryonic fibroblasts inactivation of
the Gαi2 gene resulted in a decreased Ca2+-dependent translocation of cPLA2 (Mattera
et al., 1998), and suggests that the locus for Gαi2 is downstream of the [Ca2+]i increase.
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How the PTX-sensitive Gi/Go protein is coupled to activation of PLA2 is still unclear.
None of the studies done so far have clearly established a direct physical coupling of a
G protein and the PLA2 enzyme, and it has been suggested that there may exist
intermediate or accessory proteins (Mattera et al., 1998;  Winitz et al., 1994).
1.2 Role of PKC and the MAP kinase pathway
Stimulation of the PLC pathway leads to activation of PKC. The PKC
activator phorbol ester PMA (200 nM) alone or together with ATP (100 µM) had no
effect on the AA release (I, Fig. 2D). However, the PKC inhibitor GF109203X (1 µM),
which inhibits the α, βI, βII, γ and ε isoforms of PKC (Toullec et al., 1991), or a
prolonged incubation with PMA (2 µM for 24 h), significantly  decreased the ATP-
evoked AA release (I, Fig. 2D). This is in contrast to a previous study showing that the
ATP-evoked AA release is PKC-independent in FRTL-5 cells (Smallridge and Gist,
1994). The reason for this discrepancy is not known. Another GPCR agonist,
noradrenaline, which activates PLC and PLA2 in FRTL-5 cells (Burch et al., 1986),
evokes a PKC−dependent AA release (Wang et al., 1996). The ineffectiviness of a
direct activation of PKC by PMA on AA release could be explained by the inhibitory
effect of PKC on agonist-evoked Ca2+ signals (Törnquist, 1993). Activation of PKC may
also have other inhibitory effects on signals mediated by G proteins (Boarder and
Challiss, 1992).
A role for MAP kinase in the phosphorylation and activation of PLA2 has
been suggested in many studies (Lin et al., 1993;  Nemenoff et al., 1993). Also PKC can
phosphorylate PLA2 at least in vitro (Lin et al., 1993), but the effect of PKC may occur
through the MAP kinase pathway (Qiu and Leslie, 1994). We found that inhibiting
MAP kinase using the MEK inhibitor, PD98059 (30 µM) attenuated the ATP-evoked
MAP kinase phosphorylation, as assessed by Western blot (I, Fig. 3A), and
significantly decreased, but did not abolish, the ATP-evoked AA release (I, Fig. 3B).
We also showed that PMA alone evoked phosphorylation of MAP kinase (V, Fig. 5D).
These results clearly indicate that MAP kinase is important for the ATP-evoked AA
release. However, activation of MAP kinase alone is not sufficient for PLA2
activation, since PMA was unable to evoke AA release, yet it phosphorylated MAP
kinase.
To establish whether PKC and MAP kinase acted in the same signaling
pathway in the AA release, the cells were treated together with GF109203X (1 µM) and
PD98059 (30 µM) before stimulation with ATP. In these experiments the ATP-evoked
AA release was significantly decreased when compared with cells treated with either
inhibitor alone (I, Fig. 3B). Also in Western blot studies inhibition of PKC by down-
regulation or by GF109203X attenuated the ATP-induced MAPK phosphorylation (I,
Fig. 3C, D), suggesting that PKC lies upstream of MAP kinase. However, the greater
inhibition of AA release in GF109203X- and PD98059-treated cells compared with cells
treated with either inhibitor alone suggests that PKC may also have a direct effect on
PLA2 independent of MAP kinase. In MDCK-D1 cells both MAP kinase and PKC were
necessary for maximal activation of cPLA2, however, part of the action of PKC was
independent of MAP kinase (Xing et al., 1997). Our result could also indicate two
different routes in the activation of MAP kinase: Raf-dependent and MEKK-
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dependent, which both could be activated by PKC (Siow et al., 1997). Use of both
inhibitors would result in more efficient inhibition of MAP kinase, since PD98059
inhibits only the Raf-kinase-evoked MEK activation (Alessi et al., 1995). However, it
is not known if both of these kinases are activated by ATP in FRTL-5 cells.
The pathway leading to MAP kinase activation may involve a complex
network of kinases. The Src-like kinases have been implicated in signalling from both
Gi and Gq protein-coupled receptors to MAP kinase through βγ subunits (van Biesen
et al., 1995; Luttrell et al., 1996;  Igishi and Gutkind, 1998). In our study, inhibiting Src-
like kinases by PP1 (10 µM; Hanke et al., 1996) attenuated both the ATP-evoked AA
release and MAP kinase phosphorylation (I, Fig. 4), thus suggesting that this kinase
could be involved in the activation of MAP kinase and AA release. To investigate
whether Src- and MAP kinases acted through the same pathway in the regulation of
PLA2 activity, the cells were treated with both PP1 (10 µM) and PD98059 (30 µM)
before stimulation with ATP. In these experiments the ATP-evoked AA release was
significantly decreased when compared with cells treated with either inhibitor alone
(I, Fig. 4B), suggesting that a Src-like kinase is involved in the phosphorylation of
MAP kinase, but could also act independently of MAP kinase in the AA release. This
latter finding is novel and further investigations are required to understand whether
a Src-like kinase is able to regulate the PLA2 activity independently of MAP kinase.
1.4 Effect of cAMP
Cyclic AMP and protein kinase A may have a modulatory effect on the
MAP kinase activation (Nagasaka et al., 1994;  Sevetson et al., 1993). A negative
feedback loop between the P2Y2 receptor evoked AA release and increased cAMP
level has been suggested in MDKC-D1 cells (Xing et al., 1999). However, although
cAMP and PKA form an important signaling pathway in thyroid cells, modulation of
intracellular cAMP levels by decreasing the steady-state intracellular cAMP level by
culturing the cells without TSH for 2 days (Corda et al., 1987), or by increasing the
cAMP level rapidly by addition of TSH (0.5 mU/ml; I, Fig. 5A,B) or dBucAMP (1 mM;
data not shown) to the cells cultured without TSH for 2 days, had no effect on the
ATP-evoked AA release in FRTL-5 cells. Furthermore, neither TSH (I, Fig. 5C) nor
dBucAMP (data not shown) alone evoked, or attenuated the ATP-mediated,
phosphorylation of MAP kinase. In T lymphocytes a similar kind of insensitivity of
MAP and Raf-1 kinases to cAMP has been described (Hsueh and Lai, 1995).
2. Effects of activation of PLA2 on Ca2+ fluxes (II & III)
Activation of PLA2 leads to release of AA and other fatty acids from
membrane phospholipids. Free fatty acids and eicosanoids, the metabolites of AA, can
have regulatory effects on ion fluxes in different cell types (Meves, 1994). We
therefore investigated how the metabolism of AA and different fatty acids would
affect agonist-evoked Ca2+ fluxes in FRTL-5 cells.
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2.1 Effect of arachidonic acid metabolism on the ATP-evoked Ca2+ fluxes
Preincubation of the Fura-2-loaded cells with the lipoxygenase inhibitor
nordihydroguaiaretic acid (NDGA; 30 µM), the lipoxygenase/cytochrome P-450
pathway inhibitor 5,8,11,14-eicosatetraynoic acid (ETYA; 30 µM), or the cytochrome P-
450 inhibitor econazole (30 µM) for 8-10 min decreased the ATP-evoked Ca2+ increase
in a Ca2+-containing buffer, whereas the PLA2 inhibitor 4-bromophenylacyl bromide
(4-BPB; 30 µM) did not (II, Fig. 2, 3). All of the inhibitors, except econazole, decreased
the ATP-evoked Ca2 +  release from intracellular stores (II, Fig. 2, 3). The
cyclooxygenase inhibitor indomethacin (30 µM) was without an effect on the ATP-
evoked Ca2+ transient in both Ca2+-containing and -free buffers. Furthermore,
econazole, NDGA and ETYA also inhibited the ATP-evoked store-operated Ca2 +
entry, as addition of Ca2+ ions back to the cells incubated in Ca2+-free buffer resulted in
a decreased Ca2+ entry (II, Fig. 4). These results suggested that some of the non-
cyclooxygenase products could take part in the ATP-evoked Ca2+-fluxes. Similar
observations have been made in several other cell types, where the AA metabolites
release sequestered Ca2+ (Luscinskas et al., 1990;  Snyder et al., 1986), enhance the
agonist-evoked Ca2+ release (Force et al., 1991), or regulate the store-operated Ca2+
influx (Hoebel et al., 1997). However, in our study we did not detect any Ca2+ increase
when stimulating the cells with the leukotrienes B4, C4, D4, E4, 12-HETE, 15(S)-
HPETE, 8,9-EET or 14,15-EET either alone or with ATP (data not shown).
We then tested the effect of AA on Ca2+ -fluxes. AA (30 µM) alone evoked
a small release of Ca2+ from intracellular stores and evoked the influx of Ca2+ (II, Fig.
6). The release occurred at least in part from IP3-sensitive Ca2+ stores, as in
permeabilized cells after repeted additions of IP3, AA evoked only a small release of
Ca2+ (II, Fig. 7). Addition of AA together with ATP attenuated the effect of ATP (II, Fig.
6), suggesting that the effect of AA on the ATP-evoked response could be due to
emptying the same IP3-sensitive Ca2+ stores. The mechanism by which fatty acids
mobilize intracellular Ca2+ is not known, but in other cells it is IP3-independent
(Chow and Jondal, 1990;  Gamberucci et al., 1997).
Taken together, these results show that the non-cyclooxygenase
metabolites of AA may be of importance for the ATP-induced release of sequestered
Ca2+ and for the entry of Ca2+ from extracellular space. However the identity of the
metabolite responsible remaines to be investigated. In addition, AA itself may
modulate agonist-induced release of sequestered Ca2+ in FRTL-5 cells.
2.2 Effect of fatty acids on Ca2+ fluxes
Several long chain unsaturated (oleic 18:1, arachidonic 20:4, linoleic 18:2
and linolenic 18:3 acid), long chain saturated (palmitic 16:0 and myristic 14:0 acid) and
short chain saturated (heptanoic 7:0 and valproic 8:0 acid) fatty acids were tested for
their effects on [Ca2+]i either alone, or on agonist-evoked changes in [Ca2+]i.
Extracellularly added long chain unsaturated fatty acids (30 µM) increased [Ca2+]i
when added alone, while the long chain saturated (30 µM) and short chain saturated
(30 µM) fatty acids were without effect (III, Table 1). The long chain fatty acids
attenuated also the 100 µM ATP-evoked Ca2+ transient, while the short ones did not
(III, Table 1).
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The effects of oleic acid (OA) and arachidonic acid (AA) were then tested
in detail. Both  (30 µM) evoked entry of Ca2+ from the extracellular space, which was
not inhibited by the Ca2+-channel blocker SKF 96365 (data not shown). As with AA,
also OA mobilized Ca2+ at least in part from the same intracellular stores as did ATP
(III, Fig. 2). OA also significantly decreased the ATP-evoked store-operated Ca2+ entry
(III, Fig. 2). As the ATP-evoked entry of Ba2+ was also decreased after OA treatment
(III, Fig. 3), we conclude that OA inhibited Ca2+ influx from the extracellular space, as
Ba2+ may enter the cells but cannot be extruded by plasma membrane Ca2+ATPases.
The inhibitory effect of OA on increase in [Ca2+]i was also shown using thapsigargin
(III, Fig. 4), which releases Ca2+ from intracellular stores and activates store-operated
Ca2+ entry in cells in an IP3-insensitive manner (Thastrup et al., 1990). In conclusion,
the results indicate that the effect of OA and AA on Ca2+ homeostasis was twofold:
they released Ca2+ from the intracellular stores and decreased the agonist-evoked Ca2+
entry.
2.3 Mechanisms of the inhibitory action of oleic acid and arachidonic acid on [Ca2+]i
It has been suggested that fatty acids could activate Ca2+ extrusion,
probably by activating the plasma membrane Ca2+ATPase (Breittmayer et al., 1993;
Randriamampita and Trautmann, 1990). However, we found that OA and AA did not
enhance the ATP-evoked 45Ca2+ efflux from the cells (data not shown).
 Fatty acids have been shown to activate PKC (Khan et al., 1993;
Shinomura et al., 1991), and activated PKC may inhibit agonist-evoked Ca2+ signals
(Boarder and Challiss, 1992;  Törnquist, 1993). However, inhibition of PKC by
staurosporine (200 nM) or by prolonged treatment with PMA (2 µM for 24 h) had no
effect on the OA-evoked increase in [Ca2+]i, nor did it restore the ATP-evoked Ca2+
transient in OA-treated cells (data not shown). Thus, the effects of OA are not
dependent on the activation of PKC, which agree with results obtained in several
other cell types (Gamberucci et al., 1997). We cannot, however, exclude the possibility
that some fatty acid-sensitive PKC isoform(s) were not inhibited by these treatments.
In human platelets, OA has been shown to activate PKC α, βΙΙ and δ (Khan et al.,
1993), and in cardiac myocytes AA stimulates PKC-ε redistribution (Huang et al.,
1997).
OA and AA have been shown to reduce the activity of the plasma
membrane Na+/K+ATPase (Blanco et al., 1998). Inhibition of this pump leads to
accumulation of Na+ inside the cell, and could thus result in increase in [Ca2+]i
through the activation of the Na+-Ca2+-exchanger (Törnquist, 1992). However,
substitution of Na+ by choline in the incubation buffer did not change the effect of OA
on the amplitude of [Ca2+]i, although the temporal pattern of the signal was changed
(III, Fig. 5). The ATP-evoked effect in OA-treated cells was enhanced, probably
reflecting the prevention of the Na+-Ca2+-exchanger in Na+-free buffer. However, the
ATP-evoked response was still smaller than in control cells not treated with OA.
Fatty acids can change plasma membrane potential by hyperpolarization
(Nordström et al., 1992). Depending on the cell type, hyperpolarization has been
shown to either inhibit or enhance the agonist-evoked changes in [Ca2+]i (Di Virgilio
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et al., 1987;  Oettgen et al., 1985). However, in the bisoxonol-loaded cells OA had no
effect on the membrane potential (data not shown).
Both OA and AA were found to acidify the FRTL-5 cells rapidly, as
assessed using the fluorescent pH-probe BCECF (II, Fig. 8; III, Fig. 7). Thus, the Ca2+
increase could be due to H+-tiggered activation of the Na+/H+-exhanger followed by
activation of the Na+/Ca2+-exhanger. Furthermore, the IP3-induced Ca2+ release is pH-
dependent (Guillemette and Segui, 1988), and thus acidification of the cytosol could
affect the agonist-evoked release of Ca2+. The effects of OA and AA on pHi were
compared with that of nigericin, a known K+-H+-ionophore. Addition of  0.3 µg/ml
nigericin decreased pHi to the same extent (an average of 0.2 pH units) or more than
OA or AA (II, Fig. 8; III, Fig. 8). To determine whether the fatty acid-induced decrease
in pHi caused the effect on the [Ca2+]i increase, the cells were acidified with nigericin
(0.3 µg/ml) and then stimulated with ATP. Nigericin significantly decreased the ATP-
evoked increase in [Ca2+]i (III, Fig. 8). Thus, the fatty acid evoked acidification of the
cells could at least in part lead to attenuated Ca2+ responses, probably via the pH-
sensitive IP3-evoked Ca2+ release. However, the thapsigargin-evoked Ca2+ release was
also suppressed by fatty acids and, therefore, the decrease in pHi cannot totally explain
the inhibitory effect of fatty acids. Furthermore, the mechanism by which the
acidification by fatty acids occurred is not known. Studies with model membranes
have shown that un-ionized fatty acids rapidly move to the inner leaflet of the
membrane (flip-flop movement), followed by a release of protons from the fatty acid
molecules, which induces a decrease in pHin (Kamp and Hamilton, 1992).
Previous studies have shown that bovine serum albumin (BSA), which
has a high affinity for fatty acids, can abolish the effects of fatty acids (Chow et al., 1990;
Gamberucci et al., 1997). In our study, addition of BSA (0.2%) after OA rapidly restored
the intracellular pH, and also almost restored the ATP- and thapsigargin-evoked Ca2+
responses (III, Fig. 6, 7). These results suggest that the inhibitory action of fatty acids
occurs also at the plasma membrane level.
Taken together, these results show that unsaturated fatty acids may have
effects on the agonist-evoked Ca2+ signals both in the cytosol and at the plasma
membrane. In the cytosol they release Ca2+ from the intracellular stores, and at the
plasma membrane level they inhibit Ca2+ entry. The effect of unsaturated fatty acids
on Ca2+ signalling has been shown to be directly correlated with the degree of lipid
acyl chain perturbation of the plasma membrane, and correlate with the degree of cis-
unsaturation of the fatty acids, i.e. arachidonic acid>oleic acid>>palmitic acid (Anel et
al., 1993;  Gamberucci et al., 1997). In pituitary GH3 cells it was concluded that cis- but
not trans-unsaturated or saturated fatty acids perturb the function of several integral
plasma membrane proteins: PLC, a Ca2+ entry channel and a Ca2+-extruding pump by
incorporation into the plasma membrane (Pérez et al., 1997). However, Anel et al.
(Anel et al., 1993) concluded that the effects of fatty acids were due to an altered
interaction between membrane lipids and specific proteins, which only then resulted
in alteration in the function of these proteins.
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2.4 Interactions between arachidonic acid metabolism and free fatty acids in Ca2+
signaling
The relevance of the opposing effects of free fatty acids, and the effect of
inhibition of AA metabolism, on Ca2+ homeostasis is still unresolved in FRTL-5 cells.
In canine cerebellar microsomes, AA and LTB4 have distinct effects on Ca2 +
homeostasis, i.e. LTB4 specifically activates the ryanodine receptor (RyR) whereas AA
inhibits the IP3R. It was suggested that LTB4 could be an endogenous activator of RyR
in non-muscle cells, and that the different regulation of these channels might have
consequences in the Ca2+ signaling in cells expressing both of these channels.
Furthermore, the inhibitory action of AA on IP3R and Ca2+ could represent a feedback
inhibition mechanism for the activation of cPLA2 (and thus the production of
eicosanoids), since both the translocation and phosphorylation (Ca2+-dependent MAP
kinase activation) of cPLA2 are Ca2+-dependent (Striggow and Ehrlich, 1997). In
human thymocytes and neutrophils it is speculated that the liberated free fatty acids
could antagonize the synthesis of EET (Alonso-Torre and Garcia-Sancho, 1997). In
platelets OA may serve as an intracellular messenger, as it is released into the cytosol
from the membrane by thrombin stimulation, and it also stimulates the release of
Ca2+ from intracellular stores (Siafaka-Kapadai et al., 1997). On the other hand, the
inhibitory actions of unsaturated fatty acids on Ca2+ influx in T cells is reversed by
BSA, thus leading to a suggestion that plasma albumin protects the cells from
harmful effects of fatty acids on Ca2+ homeostasis (Chow et al., 1990). It could be
possible that in FRTL-5 cells the ATP-evoked Ca2+ signals could be regulated by
potentiating or maintaining Ca2+ entry by some of the newly produced AA
metabolites inside the cells. The Ca2+ signal could then be counteracted by free fatty
acids (in an auto/paracrine manner) by inhibiting further Ca2+ influx.
In the light of recent investigations, some of the noncyclooxygenase
inhibitors used here may have effects that are not related to inhibition of AA
metabolism (Korn and Horn, 1990;  Mason et al., 1993;  Vostal and Fratantoni, 1993),
and, thus, we cannot exclude the possibility that the inhibitors had also unspecific
effects on Ca2+ homeostasis. ETYA and NDGA are fatty acid analogues, and thus could
act in a similar inhibitory manner as AA and OA (Ekokoski and Törnquist, 1994;
Huang et al., 1992). Econazole has been shown to inhibit store-operated Ca2+ influx
and sarcoplasmic reticulum Ca2+ATPase, but the exact mechanism is not known
(Christian et al., 1996;  Mason et al., 1993). We (Ekokoski and Törnquist, unpublished
observation) and others have observed that econazole increases [Ca2+]i and evokes
Ca2+ entry from the extracellular space when added to the cells alone (Jan et al., 1999;
Mason et al., 1993). However, even if these inhibitors have effects other than those
related to inhibition of AA metabolism, the AA metabolites may still act as regulators
of Ca2+ fluxes. There are recent reports showing that the AA metabolites such as 5,6-
EET are the key signals for evoking Ca2+ influx in astrocytes (Rzigalinski et al., 1999). It
is possible that there are more than one type of Ca2+ entry mechanism in a given cell
type (Barritt, 1999).
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3. Determination of P2 receptor subtypes in FRTL-5 cells (V)
There are several investigations on the effects of nucleotides on FRTL-5
cells and other thyroid cells from different species, however no thorough studies on
different ATP or other P2 receptor types have been made. On the basis of earlier
functional studies (Aloj et al., 1993;  Okajima et al., 1989;  Sato et al., 1992), several P2
receptor subtypes could be expected to be found in these cells.
Using RT-PCR analysis, we showed that the FRTL-5 cells contained
mRNA for the G protein coupled P2Y2, P2Y4 and P2Y6 receptor subtypes, and for the
transmitter-gated ion-channel P2X3, P3X4 and P2X5 subunits. (V, Fig. 1). In functional
experiments using Fura-2 loaded cells, UTP, ATP, ATPγS, and UDP were the most
potent agonists in evoking Ca2+ transients, with EC50 values of 0.2 µM, 0.5 µM, 0.7 µM
and 10.7 µM, respectively (V, Fig. 2A, B). Other nucleotides tested, α,β-meATP, 2-
MeSATP and pure ADP were weak agonists. Moreover, the nucleotide-evoked
increase in [Ca2+]i was decreased but not abolished in Ca2+-free buffer (V, Table 2),
suggesting that they released Ca2+- from intracellular stores, and that part of the
increase was due to Ca2+ influx, the magnitude of which was dependent on the
nucleotide used. In addition, PTX-pretreatment (100 ng/ml for 24 h) decreased the
Ca2+ transients evoked by all nucleotides (V, Table 2).
The results from the RT-PCR and Ca2+ experiments correlate well in favor
of the presence of P2Y2, P2Y4 and P2Y6 receptors in FRTL-5 cells, since ATP and UTP
are equipotent agonists at the rat P2Y2 and P2Y4 receptors, and UDP is a potent agonist
at the P2Y6 receptor (Bogdanov et al., 1998;  Lustig et al., 1993;  Nicholas et al., 1996;
Webb et al., 1998). The P2Y1 receptor agonist ADP (Léon et al., 1997), after hexokinase
treatment, induced Ca2+ transient only with low potency and efficacy, thus
confirming the absence of this receptor subtype in these cells.
The presence of the P2X receptor subunits is more difficult to show with
functional experiments, as all of the P2X receptor subunits detected in FRTL-5 cells are
activated by ATP, and presently there are no specific antagonists available to
discriminate between these receptor types (North and Barnard, 1997). 2-MeSATP and
αβ-meATP, which are the most potent agonists at the P2X3 receptor, induced Ca2+
transients with low potency. Of the P2X4 and P2X5 receptor agonists (ATPγS and 2-
MeSATP), only ATPγS gave potent Ca2+ responses. Furthermore, also the P2X
agonist-evoked Ca2+ transients were attenuated by PTX. These results suggest that the
P2X receptor transcripts may not be translated into proteins, or if they are translated
they do not assemble into functional channels. It is also possible that the method used
here is insufficient to detect the responses by P2X receptors. Especially the P2X3
receptor shows rapid desensitization kinetics, and thus the effect through this
receptor subtype may remain undetected. Clearly, to establish whether the P2X
receptors are functioning in FRTL-5 cells, further experiments are warranted, such as
electrophysiological measurements.
Taken together, the six different types of P2 receptor transcripts found in
these cells is far more than was expected on the basis of pharmacological experiments.
There are no earlier studies on the expression of P2 receptors in native thyroid tissue
of any animal species, and therefore we cannot compare the observed expression
profile with that of thyroid cells. In a recent study it was shown that pancreatic duct
cells, which are polarized epithelial cells, express multiple P2Y and P2X receptors (Luo
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et al., 1999). The distribution of the P2 receptor subtypes was different in the luminal
and basolateral membranes, however subtypes from both receptor classes were
expressed in both membranes. The source of nucleotides activating these receptors is
also different, that is, the basolateral receptors are stimulated by ATP secreted from
purinergic neurones, and the luminal receptors stimulated by ATP secreted e.g. by
acinar cells. Many of the receptors were shown to activate Cl- channels, suggesting
that they might have a physiological role in the regulation of pancreatic duct cell
function. In a recent report in polarized porcine thyroid cell culture it was shown that
a UTP-preferring receptor (EC50 of 0.08 µM for UTP), located on the apical membrane,
was connected to regulation of Na+ absorption (Bourke et al., 1999). It was suggested
that this receptor, which on the pharmacological basis might be the P2Y4 subtype,
could have a role in the physiological regulation of follicle volume. In this study, also
ATP and UDP seemed to act as agonists with EC50 values of 6.3 - 6.6 µM, which,
although not mentioned in the article, could indicate separate receptors at least for
uridine nucleotides. Further experiments are needed to establish how the various P2
receptors work and interact in polarized thyroid cell cultures.
4. The mitogenic effect of ATP  (IV & V)
4.1 The ATP evoked enhancement of DNA-synthesis
There are several reports showing that extracellular ATP alone acts as a
mitogen (Erlinge et al., 1993;  Wang et al., 1992), or acts synergistically with other
mitogens in various cell types (Erlinge et al., 1995;  Huang et al., 1989;  Ishikawa et al.,
1994). Here we showed that ATP was able to enhance DNA-synthesis in FRTL-5 cells
incubated in medium containing serum and insulin (5H medium) or TSH (6H
medium; IV, Fig. 1), but not in quiescent cells (data not shown), or in cells incubated
in 4H medium (medium with serum but without TSH and insulin; IV, Fig. 1). The
effect of ATP was dose- and time-dependent. Furthermore, ATP increased the cell
numbers by 30% in the 5H medium (IV, Fig. 2). These results suggested that ATP
acted as a comitogen, rather than as an independent mitogen in FRTL-5 cells. The
effect of ATP was not due to the breakdown product adenosine, as adenosine
deaminase did not have an effect on the ATP-evoked 3H-thymidine incorporation
(data not shown). Furthermore, ATP did not have an effect on the binding of I125-
TSH in FRTL-5 cells (data not shown), indicating that ATP did not affect the affinity
or the number of the TSH receptors.
4.2 Effects of other nucleotides on DNA-synthesis
We then wanted to investigate whether also other nucleotides could
evoke mitogenesis in FRTL-5 cells, and also to determine through which P2 receptor
subtype ATP exerted its action. UTP, UDP and ATPγS enhanced the 3H-thymidine
incorporation in a concentration-dependent manner (V, Fig. 3A), while the effect of
αβ-meATP was very weak, and 2-MeSATP was totally ineffective (data not shown).
The effects of ATP and UTP were decreased by pretreatment of the cells with PTX
whereas it had no effect on the UDP- or ATPγS-evoked responses (V, Fig. 3B). In
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paper IV the effect of ATP was almost totally abolished with PTX-treatment (IV, Fig.
3C), which may be due to the different cell batch used. Taken together, the results
suggest the involvement of at least three receptor subtypes in nucleotide-evoked
mitogenesis: P2Y2 and/or P2Y4 in response to ATP and UTP; and P2Y6 in response to
UDP and ATPγS. In several cell types the P2 U  receptor (P2Y2 in the new
nomenclature) has been shown to take part in the activation of cell division (Kaplan
et al., 1996;  Malam-Souley et al., 1996;  Miyagi et al., 1996). Also a role for the P2Y4
receptor has been suggested in smooth muscle cell division (Harper et al., 1998).
However, at present, without specific tools, it is impossible to discriminate between
mitogenic P2 receptor subtypes in FRTL-5 cells.
4.3 Interaction between P1 and P2 receptor systems
In addition to P2 receptors, FRTL-5 cells also possess P1 adenosine
receptors. Studies have shown that the P2 receptor-mediated responses may be
potentiated by the P1 receptors in FRTL-5 cells (Nazarea et al., 1991;  Okajima et al.,
1989). Okajima et al. (1989) proposed the existence of P2p and P2i receptor types in
FRTL-5 cells, which could explain the possible interactions between these two (P1 and
P2) receptor systems (Okajima et al., 1989). In their model, the P2p receptor is coupled
to a PTX-insensitive G protein and activates PLC, whereas the P2i or A1 receptor is
coupled to a PTX-sensitive G protein, and negatively regulates adenylate cyclase,
leading to an enhancement of the signal mediated by the PLC-pathway. According to
their model, ATP is able to bind to both receptor types, whereas GTP binds only to the
P2p type, and PIA, an adenosine derivative, binds only to the P2i type (Okajima et al.,
1989). To test the interaction of P1 and P2 receptor systems in the DNA-synthesis, the
cells were stimulated with GTP and PIA. GTP per se  enhanced the incorporation of
3H-thymidine, but only in the presence of TSH (IV, Fig. 4A). PIA decreased the basal
as well as the ATP-induced incorporation of 3H-thymidine in the presence of both
insulin and TSH (IV, Fig. 4A, B). This is consistent with studies by Moses et al. (Moses
et al., 1989) and Vainio et al. (Vainio et al., 1997), who showed that adenosine has
inhibitory effects on TSH, insulin and PMA-evoked DNA-synthesis. Furthermore,
when added together, GTP and PIA did not mimic the action of ATP (data not
shown), and thus we could not confirm the proposed hypothesis. This may be due to
more complex signaling mechanism in evoking DNA-synthesis than in evoking Ca2+
transients.
4.4 Mechanisms of the ATP-enhanced DNA-synthesis
We then investigated the mechanism(s) by which ATP enhanced DNA-
synthesis. A role for PKC has been suggested in mitogenesis (Lombardi et al., 1988;
Roger et al., 1997). In our study, PMA (200 nM) per se in the presence of insulin
increased, but in the presence of TSH, decreased, the 3H-thymidine incorporation (IV,
Fig. 1). The observed mitotic and antimitotic effects of PMA here are consistent with
other studies in FRTL-5 cells (Akiguchi et al., 1993;  Kraiem et al., 1995), and the
antimitotic effect probably reflects an inhibitory action of PMA on the cAMP-
mediated response of TSH (Roger et al., 1997). Inhibition of PKC by downregulation
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with PMA (2 µM 24 h) did not have a significant effect on the ATP-stimulated 3H-
thymidine incorporation (IV, Fig. 3A). Furthermore, addition of ATP and PMA
together resulted in an additive response in 3H-thymidine incorporation (IV, Fig. 3B).
Similar observations of a minor role of PKC in ATP-induced mitogenesis have been
made in other cell types, such as smooth muscle cells (Erlinge et al., 1993). However,
we cannot exclude the possibility that some PKC isoforms were not inactivated by
PMA-treatment. Such isoforms (PKC ζ and λ) have recently been proposed to have a
role in mitogenesis (Toker, 1998). The ζ isoform is not inactivated by downregulation
in FRTL-5 cells (Wang et al., 1995).
Ca2+ ions play important regulatory functions in the cell cycle (Santella,
1998). Here, the basal as well as the ATP-induced incorporation of 3H-thymidine was
dose-dependently decreased by Ni2+ (IV, Fig. 7), suggesting that Ca2+ is of general
importance in cell proliferation. The effect of Ca2+ can be mediated through
calmodulin and Ca2+/CaM kinase II (Santella, 1998). Inhibition of calmodulin with
calmidazolium or phenoxybenzamine, or inhibition of the CaM kinase II with KN-62
dose-dependently decreased the basal and the ATP-induced DNA-synthesis (IV, Fig.
7). These results suggested that these effectors of Ca2+ signaling may play a role in
FRTL-5 cell proliferation. However, an increase in [Ca2+]i alone is not sufficient for
cells to start proliferation, since the Ca2+ mobilizing agents thapsigargin and
ionomycin either decreased or were without an effect on 3H-thymidine incorporation
(data not shown).
In previous studies of FRTL-5 cells, many of the growth-promoting
factors, such as TSH, IGF-I and serum, have been shown to induce the production of
cyclooxygenase metabolites (Tahara et al., 1991). Furthermore, noradrenaline has been
shown to induce DNA-synthesis via an autocrine PGE2 production (Burch et al.,
1986). In the present study incubation of the cells with indomethacin (30 µM) did not
decrease the ATP-induced incorporation of 3H-thymidine (data not shown).
Furthermore, addition of AA per se or together with ATP, did not affect the 3H -
thymidine incorporation (data not shown). Also the noncyclooxygenase metabolites
15(S)-HETE, 15(S)-HPETE, 8,9-EET and 14,15-EET were without an effect on 3H -
thymidine incorporation (Ekokoski and Törnquist, unpublished observation).
The MAP kinase pathway is one of the key elements in regulating cell
growth in many cell types (Widmann et al., 1999). In FRTL-5 cells, ATP induced a
transient phosphorylation of MAP kinase, which was initiated within 0.5 min and
lasted for at least 10 min (IV, Fig. 5A). To investigate the mechanism of ATP-evoked
MAP kinase phosphorylation, the cells were treated with PTX (50 ng/ml for 24 h). The
phosphorylation was partially inhibited by PTX treatment (IV, Fig. 5B), suggesting that
it was mediated through both Gi and Gq proteins. The phosphorylation of MAP
kinase was a Ca2+-independent process, as it was not inhibited by Ni2+ (3 mM; IV, Fig.
5C) or in Ca2+-free buffer (Ekokoski and Törnquist, unpublished observation). Also,
we have not been able to detect phosphorylation of MAP kinase in response to
thapsigargin (Ekokoski and Törnquist, unpublished observation), suggesting that an
increase in Ca2+ is not sufficient to phosphorylate the kinase, a result consistent with
others who have shown that MAP kinase activation may be Ca2+-independent (Chao
et al., 1992). The MEK inhibitor PD98059 (30 µM) inhibited the ATP- and PMA-
induced MAP kinase phosphorylation, and also decreased the ATP- and PMA-
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induced 3H-thymidine incorporation (V, Fig. 5D, 6), suggesting that MAP kinase has a
role in DNA-synthesis. However,  inhibition of MEK did not totally block DNA-
synthesis, and since ATP-induced MAP kinase phosphorylation was detected in
quiescent cells, which do not proliferate, these results suggest that the MAP kinase
pathway is not sufficient to alone induce cell proliferation, and suggest that additional
factors are needed. The reason why inhibition of PKC and MEK did not produce
similar effects on DNA-synthesis, as in MAP kinase phosphorylation experiments (I,
Fig. 3A, C, D), is not known, but a possibility exists that some residual MAP kinase
activity could remain after PKC inhibition. Furthermore, the effect of PD98059 on 3H-
thymidine incorporation was more pronounced in ATP-stimulated cells than in
PMA-stimulated cells, which indicates that activation of PKC leads also to MAP
kinase independent effects on DNA-synthesis.
4.5 Nucleotide-evoked expression of immediate early gene products c-Fos and c-Jun
Many mitogens activate the expression of immediate early genes (IEGs)
(Herschmann, 1991). We wanted to examine whether the nucleotides that induced
3H-thymidine incorporation also could induce the expression of the protooncogenes
c-Fos and c-Jun. ATP, UTP, UDP and ATPγS dose-dependently induced the expression
of c-Fos and c-Jun proteins as assessed by Western blotting (V, Fig. 4A). The effect of
αβ-meATP was weak and 2-MeSATP was totally ineffective in these experiments. The
expression of c-Fos and c-Jun peaked at 1 hour, and no expression could be seen after 4
hours (IV, Fig. 6A). The expression of c-Fos and c-Jun induced by ATP, UTP, UDP and
ATPγS was decreased in cells pretreated with PTX (V, Fig. 4B).
We then wanted to investigate by which mechanisms ATP induced the
expression of c-Fos and c-Jun. The effect of Ca2+ was investigated using EGTA (3 mM),
BAPTA (20 µM) or Ni2+ (4 mM), all of which decreased the ATP-induced expression
of c-Fos and c-Jun (V, Fig. 5A). These results suggested that Ca2+ is important for c-
Fos/c-Jun expression. To investigate the mechanism of Ca2+ regulation in expression,
the cells were treated with the calmodulin inhibitors calmidazolium (30  µM) and
fluphenazine (30 µM), or the CaMK II inhibitor KN-62 (10 µM). However, these
treatments did not have an effect on the ATP-induced c-Fos and c-Jun expression
(data not shown).
The possible role of PKC in protooncogene expression was then
examined. Stimulation of the cells with PMA (200 nM) induced the expression of c-
Fos and c-Jun (V, Fig. 5B). Furthermore, the ATP-induced c-Fos and c-Jun expression
was decreased by PKC inhibition using the PKC-inhibitors H-7 (30 µM) or GF109203X
(0.01-10 µM), or by a prolonged incubation with PMA (2 µM for 24 h; V, Fig. 5B),
indicating that PKC was important for the ATP-induced c-Fos/c-Jun expression.
MAP kinase may regulate cell division and AP-1 activity (Karin, 1995).
We showed that inhibition of MEK by PD98059 (30 µM) decreased the expression of c-
Fos and c-Jun in response to both ATP and PMA (V, Fig. 5E), suggesting that this
pathway takes part in protooncogene regulation.
51
4.6 Correlation between DNA-synthesis and c-Fos and c-Jun expression
The obtained results show that ATP induces 3H-thymidine incorporation
and the expression of c-Fos and c-Jun genes, and these effects are in part regulated by
the same mechanisms (i.e. an increase in [Ca2+]i, activation of MAPK). However,
some findings on the regulation of c-Fos and c-Jun expression are not consistent with
the 3H-thymidine incorporation results (i.e. inhibition of PKC, inhibition of
calmodulin/CaM kinase II), and challenge the assumption that these phenomena are
strictly connected. Clearly, the expression of these genes is not sufficient for the cells
to commit to divide, since the expression was also induced in quiescent cells where
no 3H-thymidine incorporation occurs in response to ATP.
In dog thyrocytes, carbachol, which activates the phosphatidylinositol-
Ca2+-pathway, induced the expression of c-fos and c-myc genes but did not induce
DNA-synthesis even in the presence of insulin (Raspé et al., 1992). Also, in dog
thyroid cells, mitogens using different pathways regulate the expression of
protooncogenes in a differential manner. Whereas the expression of c-jun and jun D
were induced by protein tyrosine kinase and PKC, TSH and cAMP downregulated c-
jun expression but still exerted a synergistic action on the proliferation together with
the other mitogenic pathways (Reuse et al., 1991). In those cells the expression of c-jun
does not correlate with cell proliferation, but instead, junB was found to correlate best
with the proliferative phase (Roger et al., 1997). However, it was suggested that c-jun
could be involved in the negative control of expression of differentiation. On the
other hand, in human thyroid cells, an association between cell proliferation and the
expression of c-fos and c-jun has been suggested in TSH, PMA and EGF-stimulated
cells (Heinrich and Kraiem, 1997). In a previous study of FRTL-5 cells, it was shown
that there is no simple correlation between the ability of TSH, insulin, IGF-I, PMA
and α1-agonists to increase c-fos/c-myc expression, increase cell number or induce
DNA-synthesis, and at least the insulin/IGF-I evoked protooncogene expression
could be coupled to functional responses, such as thyroglobulin gene expression
(Isozaki and Kohn, 1987). Whether the c-fos and c-jun gene expression is needed in
the ATP-enhanced DNA-synthesis, needs further investigations.
4.7 ATP-evoked comitogenesis: possible mechanisms
 The observation that ATP itself is not sufficient to trigger mitogenesis in
FRTL-5 cells is in agreement with studies performed in other cell types. A role for
ATP as a competence factor has been suggested in cells where ATP has the ability to
induce limited progression of the cell cycle from G0 to G1 (Malam- Souley et al., 1993).
Contradictory conclusions were reached by Migyagi et al. (1996) showing that UTP and
ATP act as progression factors rather that competence factors, by their action at a P2U
receptor. It was hypothesized that different P2 receptor subtypes could regulate cell
cycle at different levels, and the subtypes may be differentially expressed during the
cell cycle depending on the culture conditions and comitogens and growth factors
(Abbracchio and Burnstock, 1998).
Most proliferative growth factors are capable of activating a number of
signaling pathways, one of which is the phosphatidylinositol-Ca2+-pathway. It has
been suggested that activation of the phosphatidylinositol-Ca2+-pathway may cause
cell division (Berridge, 1995). However, there are also contradictory reports showing
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that there is no correlation between the activation of this pathway and increased cell
proliferation. In vascular smooth muscle cells, ATP was shown to increase Ca2 +
concentrations, but the mitogenic response was not mediated through phospholipase
C (Erlinge et al., 1993). Carbachol and bradykinin, another activator of the
phosphatidylinositol-Ca2+-pathway, were inefficient in inducing DNA-synthesis in
dog thyrocytes even in the presence of insulin and serum (Raspé et al., 1992), which,
thus, indicates differences between thyroid cells from different species. In conclusion,
if a possible mitogen produces Ca2+ signals, it does not necessarily mean that Ca2+ has
a direct role in initiating proliferation. However, Ca2+ nevertheless has a general role
in regulating various steps in the cell cycle.
The mechanism by which GPCRs regulate cell proliferation remains
poorly understood (Gutkind, 1998). Several studies have shown that some GPCRs
may stimulate ligand-independent tyrosine-phosphorylation of the PDGF receptor
(Duff et al., 1992), the IGF-1 receptor beta subunit (Rao et al., 1995), and the EGF
receptor (Daub et al., 1996). It has been suggested that the RTKs may function as a
scaffolding structure or as an adaptor protein to which other signaling proteins may
be recruited in response to GPCRs signaling (Daub et al., 1996). Whether this could be
the mechanism for the effect of ATP in FRTL-5 cells, remains to be examined.
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SUMMARY AND CONCLUSIONS
Increasing evidence shows that extracellular ATP is essential for the
normal physiology of many cells and tissues, and that it is a potent agonist in
endocrine cells.  Extracellular nucleotides have been shown to have effects in thyroid
cells of different species. The present study deals with the effects of extracellular ATP
in FRTL-5 cells, an established rat thyroid cell line. Two main areas were examined: 1)
the regulation of PLA2 activity and the interaction of this pathway with the PLC-
signaling pathway, and 2) the mitogenic effect of ATP. It is clear that on the basis of
experiments carried out using a cell line, direct conclusions concerning the function
of the thyroid cells in vivo cannot be made. This experimental cell model
nevertheless serves as a model for the elucidation of intracellular signal transduction
pathways in thyroid cells.
We showed that extracellular ATP regulates PLA2 activation and AA
release through a PTX-sensitive Gi/o protein-coupled receptor. An increase in [Ca2+ ]i
and activation of the MAP kinase cascade are also important for the ATP-evoked AA
release. Furthermore, the AA release is cAMP-insensitive. The metabolism of AA
may be important for the ATP-evoked Ca2+ signaling, since blocking of
noncyclooxygenase enzymes resulted in an inhibition of the ATP-induced Ca2 +
transients, and suggests that some AA metabolite(s) regulates the ATP-evoked Ca2+
signals. On the other hand, free long chain unsaturated fatty acids, which may also be
liberated by the action of PLA2, inhibit the ATP-evoked Ca2+ signals, suggesting a
regulatory role for these fatty acids. A summary of the presently reported effects of
ATP on PLA2 and PLC pathways is shown in Figure 8. Although the physiological
role of the interaction of PLC and PLA2 remains to be studied in these cells, both
pathways have been shown to take part in the regulation of for example iodide efflux
in response to ATP. Thus, ATP could be a regulator of thyroid cell functions through
these signaling pathways.
                 
Figure 8. Summary of the interaction between PLC and PLA2 pathways in response to
ATP in FRTL-5 cells.
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ATP acts as a co-mitogen by enhancing the effect of insulin and TSH on
DNA-synthesis. ATP also induces proliferation in insulin-stimulated cells. The PLC,
but not the PLA2 pathway, seems to take part in the regulation of this co-mitogenic
effect, through the action of Ca2+, but independently of PKC. Also, the effect of ATP
was shown to be mediated, at least in part, through the MAP kinase pathway. The
regulation of the expression of protooncogenes c-fos and c-jun in response to ATP
and other nucleotides did not correlate well with the results obtained by measuring
DNA-synthesis, therefore no generalization of the involvement of c-fos and c-jun in
mitogenesis can be made. A summary of the effect of ATP on mitogenesis is
presented in Figure 9. In conclusion, ATP seems to act also as a long term regulator of
thyroid cells in terms of cell proliferation.
                              
Figure 9. Summary of the co-mitogenic effect of ATP on FRTL-5 cell proliferation.
An unexpected finding was the presence of transcripts for six different P2
receptor subtypes, the G protein-coupled P2Y2/4/6 receptors, and the transmitter-gated
ion channel P2X3/4/5 subunits, which is far more than could have been expected on
the basis of previous pharmacological experiments with these cells. It is not possible
at present to assign specific roles for each of the P2 receptors in FRTL-5 cells. However,
at least the G protein-coupled P2Y receptor subtypes seem to regulate DNA-synthesis
and protooncogene expression in these cells. It remains to be examined whether the
detected P2X receptor transcripts are translated and form functional receptors. Taken
together, this is the first report showing P2 receptor subtypes in thyroid cells. The
present results provide a basis for future studies in define the role of the different P2
receptor subtypes in the thyroid gland.
Recent studies have shown that ATP is constitutively released to the
extracellular space from resting cells in vitro. This is an interesting phenomenon as it
may indicate a constant para/autocrine effect of the nucleotides on the cells. Albeit
the source(s) of extracellular nucleotides remains to be examined in the thyroid gland,
ATP  is clearly an important regulator of thyroid cell functions, and the interaction of
ATP with other signaling pathways a challenging subject of future studies.
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